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ABSTRACT 
Complex I (E.C. 1.6.99.3) of the bacterium Escherichia coli is considered to be 
the minimal form of the type-I NADH dehydrogenase, the first enzyme complex in the 
respiratory chain. Because of its small size and relative simplicity, the E. coli enzyme has 
become a model in the endeavor to identify and characterize the mechanism( s) by which 
cells regulate the synthesis and assembly of this large respiratory complex. 
To begin dissecting the processes by which E. coli cells regulate the expression of 
nuo and the assembly of complex I, we undertook a genetic analysis of the fourteen 
structural gene locus nuo that encodes the fourteen Nuo subunits comprising E. coli 
complex I. We performed studies on an coisogenic collection of nuo mutants that focus 
on the physiological, biochemical, and molecular consequences caused by the lack of or 
defects in several Nuo subunits. Our findings provide insight into the regulation of nuo 
expression and complex I assembly. In particular, we acquired evidence that the 
peripheral subunit, NuoG, is essential for complex I function and that it plays a role in the 
regulation of nuo expression and/or the assembly of complex I. Furthermore, we 
demonstrated that Nuo subunits within the membrane arm of complex I may have dual 
functions, working in conjunction with NuoG to coordinate transcription at the nuo 
promoter thus providing a feedback mechanism of regulation. And, finally, we 
xm 
uncovered a seemingly complicated scheme of multiple sigma factor interaction at the 
nuo promoter. 
XIV 
CHAPTER! 
INTRODUCTION 
Regulation of Synthesis and Assembly of Multisubunit Complexes 
The ability of a prokaryotic cell to tightly coordinate the synthesis and assembly 
of large multisubunit complexes is crucial to its ability to react in response to its 
environment (both internal and external) and to maintain efficient energy utilization. 
Cells have devised a number of mechanisms to accomplish such coordinated regulation. 
Three multisubunit complexes whose regulation is well understood are the Escherichia 
coli and Salmonella typhimurium flagellar apparatus (59, 70, 71), the Rhodobacter 
capsulatus photosystem components (7), and ribosomes (84). 
Flagellar gene expression is coupled through a system ofhierarchial operons in 
which the flagellar genes are clustered. The expression of one operon is dependent upon 
the product( s) produced by another through an alternative sigma factor and other 
transcription factors (71). Negative regulation of the late operons is achieved in part 
through the anti-sigma factor FlgM. FlgM binds to the product ofthefliA gene, 0 28, thus 
preventing expression of 0 28-dependent operons (70, 71). However, when assembly of 
the flagellar apparatus reaches the stage of morphogenesis at which flagellin proteins can 
be exported from the cell (to form the flagellar filament) through the apparatus, FlgM is 
also exported out of the cell into the medium thus lowering its intracellular concentration. 
1 
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In turn, 0 28 is released and becomes free to function in transcription initiation (59, 70). 
This mechanism serves as a "developmental checkpoint" that links the regulation of gene 
expression and assembly. 
Expression of the R. capsulatus photosystem components are also tightly 
regulated (7). Expression of pigment biosynthesis genes is coupled to expression of the 
structural genes through various operons that overlap one another, designated 
"superoperons". This provides for a balanced synthesis of the light-harvesting and 
photopigment components. Furthermore, the various operons are controlled by different 
transcription factors including an aerobic repressor, a two-component regulatory system, 
and possibly an unidentified alternative sigma factor. 
Many of the mechanisms that regulate ribosome synthesis and assembly are in the 
form of translation-dependent feedback inhibition (84). Certain freer-proteins can act as 
feedback inhibitors of translation of their own mRNA thereby coupling the synthesis of r-
proteins with ribosome assembly. Other r-proteins can regulate the synthesis of multiple 
r-proteins from a polycistronic mRNA molecule. 
Complex I in E. coli is also a large, multisubunit complex whose synthesis and 
assembly we hypothesize are likely to be regulated, perhaps by the very subunits that 
comprise complex I. Like many other multisubunit complexes, the genes that encode for 
complex I are clustered (38, 68). Since the genes that encode the subunits of complex I 
are not organized into several operons but rather localized within a single locus (nuo), we 
may focus on the concomitant regulation of the promoter proximal and promoter distal 
genes rather than looking for a hierarchial scheme of regulation. In thinking about this 
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possibility of regulation, we need to keep in mind that all of the subunits encoded by the 
nuo genes are known to have structural and/or enzymatic functions. The stoichiometry 
of"l" for each subunit of complex I (38, 68) suggests the presence ofregulatory 
components which coordinately balance the synthesis of every subunit. Further evidence 
for a regulatory scheme is that the nuo locus is expressed in response to a number of 
environmental stimuli (12, 106). 
E. coli complex I as a Model System 
Researchers have begun to utilize complex I of E. coli, and that of its close 
relative S. typhimurium, to identify and characterize the mechanism( s) by which cells i) 
regulate the synthesis and assembly of this large respiratory complex (3, 12, 106), ii) to 
investigate the diverse physiological consequences caused by defects in this enzyme ( 4, 
16, 91, 126), and iii) to study the mechanism of electron and proton translocation (3 7, 
110, 114). These studies provide insight into bacterial energy metabolism and 
macromolecular complex synthesis and assembly. Moreover, because of its relatively 
small size and simplicity, E. coli complex I provides an excellent model system to study 
mitochondrial complex I. Ultimately, these efforts will contribute to the medical 
community's understanding of the relationship between defects in complex I and the 
processes that lead to aging and diseases such as Parkinson's disease. 
To begin dissecting the processes by which E. coli cells regulate the expression of 
nuo and the assembly of complex I, we undertook a genetic analysis of the nuo locus. 
Here, we present the results of studies, performed on an isogenic collection of nuo 
mutants, that focus on the physiological, biochemical, and molecular consequences 
caused by the lack of or defects in several Nuo subunits. In particular, we present · 
evidence that NuoG, a peripheral subunit, is essential for complex I function and that it 
plays a role in the regulation of nuo expression and/or the assembly of complex I. We 
also present data consistent with a role for another subunit, the membrane subunit NuoA 
(a membrane subunit), in the regulation of nuo expression. Finally, we provide data that 
suggests multiple levels of sigma factor regulation at the nuo promoter. 
Complex I, The Enzyme 
Complex I (E.C. 1.6.99.3; NADH:ubiquinone oxidoreductase), a type-I NADH 
dehydrogenase that couples the oxidation ofNADH-reducing equivalents to the 
generation of a proton motive force, is the first enzyme complex of the respiratory chain 
(2, 82, 109, 111, 116) (Fig. 1). It performs the reaction 
where Q refers to ubiquinone and H\ and H\ refer to the protons taken up from the 
negative side of the membrane and delivered to the positive side of the membrane, 
respectively ( 40). Complex I and related proton-pumping NADH dehydrogenases have 
been identified in a variety of eukaryotic organisms (111, 116 for review) as well as in 
the a.-, P-, y-, and o-subdivisions of eubacteria (64, 66, 114, 119). 
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Fig. 1. Schematic of the E. coli aerobic respiratory chain. NADH reducing 
equivalents from glycolysis and the TCA cycle enter the respiratory chain through 
complex I, a type I NADH-dehydrogenase. Complex I couples the oxidation ofNADH to 
the generation of a proton motive force. It passes the electrons from the oxidation step to 
the quinone pool where they then are passed on to either of two terminal oxidases and 
finally to oxygen. The proton motive force generated by complex I drives the formation 
of ATP. NDH-11, a type II NADH-dehydrogenase also oxidizes NADH, but does not 
generate a proton motive force. 
2H+ 
c7 
NADH~ 
NAD+ 
NDH-11 
NADH-
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tvoe-11 
2H+ 
type 
idas 
02 
0\ 
7 
Escherichia coli NADH Dehydrogenases 
The Escherichia coli complex I, considered the minimal form of the enzyme·, 
consists of fourteen polypeptide subunits (38, 67, 68, 73, 114), instead of the 40-50 
structural and accessory subunits associated with the homologous eukaryotic 
mitochondrial enzyme (72, 111, 115, 116), and contains a numbers of prosthetic groups 
(FMN and Fe-S centers) (38, 67, 68). The E.coli enzyme is encoded by the fourteen 
gene locus, nuo (NADH:ybiquinone Qxidoreductase), located between 49.2 and 49.6 min 
on the chromosome (16, 68). In addition, E. coli possesses a second, single polypeptide 
NADH dehydrogenase (type-II), NDH-II, which also oxidizes NADH and contains a 
FAD prosthetic group (61, 62). However, this process is not coupled to the generation of 
a proton motive force (73). This second NADH dehydrogenase is encoded by the ndh 
(NADH .dehydrogenase) gene located at 22 min on the chromosome (16, 124). 
E. coli complex I and nuo Locus 
E. coli complex I resembles eukaryotic complex I in many ways (37, 38, 68, 114): 
it consists of subunits homologous to those found in all proton-translocating 
NADH:ubiquinone oxidoreductases ( complex I) studied thus far (Table 1 ); it is 
comprised of a large number of subunits relative to the number that comprise other 
respiratory enzymes; it contains FMN and Fe-S center prosthetic groups; it performs the 
enzymatic reaction that does eukaryotic complex I; and it is sensitive to the a number of 
the same inhibitors. Additionally, it possesses an L-shaped topography (33, 46) like its 
Neurospora crassa homolog (58) and can be purified as three distinct fragments. 
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Table 1. The Nuo subunits and their homologs. E.c. refers to Escherichia coli, S.t. to 
Salmonella typhimurium, P.c. to Paracoccus denitrifzcans, T.t. to Thermus thermophilus, 
B.t. to Bov taurus, and Ne. to Neurospora crassa. IP refers to iron-sulfur protein fraction, 
FP to flavoprotein fraction. *, mitochondrial-encoded. The data for various proteins 
comes from the following sources: E.coli and B. taurus proteins (114); S. typhimurium 
proteins (3 and Genbank accession numbers L22504 and U2521); P. denitrifzcans (120); 
T. thermopilus (122); R. capsulatus (26-28); N crassa (5, 33). The predicted functions 
are based on data from a number of sources (37-40, 68). 
TABLE 1. The Nuo subunits and their homologs 
E. c. s. t. P. d. T. t. R. c. B. t. N. c. Predicted function or 
cofactor binding 
NuoA NuoA NQO7 NQO7 NuoA ND3* ND3* 
NuoB NuoB NQO6 NQO6 NuoB PSST 1 X [4Fe-4S] 
NuoC NuoC NQO5 NQO5 NuoC 30 IP Nuo31 
NuoD NuoD NQ04 NQ04 NuoD 49 IP Nuo49 
NuoE NuoE NQO2 NQO2 NuoE 24FP Nuo24 1 X [2Fe-2S] 
NuoF NuoF NQOl NQOl NuoF 51 FP Nuo51 NADH-binding; FMN; 
1 X [4Fe-4S] 
NuoG NuoG NQO3 NQO3 NuoG 75 IP Nuo78 2 X [4Fe-4S]; 
1 X [2Fe-2S] 
NuoH NuoH NQO8 NQO8 NuoH NDl* NDl* ubiquinone-binding 
(NdhA) 
Nuol Nuol NQO9 NQO9 Nuol (Ndhl) TYKY 2 X [4Fe-4S] 
NuoJ NuoJ NQOlO NQOlO NuoJ ND6* ND6* 
NuoK NuoK NQOll NQOll NuoK ND4L* ND4L* 
NuoL NuoL NQO12 NQO12 NuoL ND5* ND5* proton translocation 
NuoM NuoM NQO13 NQO13 NuoM ND4* ND4* proton translocation 
NuoN NuoN NQO14 NQO14 NuoN ND2* ND2* proton translocation 
\0 
Whereas eukaryotic complex I can be dissected into a peripheral arm and a membrane 
arm, the E. coli enzyme is comprised of three subcomplexes referred to as the peripheral, 
connecting, and membrane fragments ( 67) (Fig. 2A). 
The organization of nuo (38, 68, 114) (Fig. 2B) and related genes is conserved in 
several other bacteria, including Salmonella typhimurium (3), Paracoccus denitrificans 
(118), Rhodobacter capsulatus (27), and Thermus thermophilus (122). The 5' half of the 
nuo locus contains a promoter (nuoP) located upstream of nuoA (3, 12, 114) and the 
majority of genes that encode subunits homologous to the nuclear-encoded subunits of 
eukaryotic complex I (38, 67, 68, 114). In contrast, the 3' half contains the majority of 
the genes that encode subunits homologous to the mitochondrial-encoded subunits of 
eukaryotic complex I (38, 67, 68, 114), as well as sequences resembling transcriptional 
termination signals (114). 
The subunit composition of the three fragments of E. coli complex I correlates 
approximately with the organization of the fourteen structural genes, nuoA-nuoN (38, 68, 
114) (Fig. 2A & B). Whereas the nuclear homologs NuoE, NuoF, and NuoG constitute 
the peripheral fragment (also referred to as the NADH dehydrogenase fragment or NDF), 
the nuclear homologs NuoB, NuoC, NuoD, and Nuol comprise the connecting fragment. 
The mitochondrial homo logs NuoA, NuoH, NuoJ, NuoK, NuoL, NuoM, and NuoN 
constitute the membrane fragment ( 67). Based on predictions from conserved sequence 
motifs (38, 63, 68), complex I inhibitor studies (37), and evolutionary relationships (39, 
40), the E. coli complex I subunits which bind substrates, harbor redox groups, and 
participate in proton translocation have been identified putatively (Table 1 ). The 
11 
peripheral fragment is believed to be the electron input site (38); the membrane fragment 
contains the ubiquinone-binding site (38, 68) and is thought to be involved in proton 
translocation (39, 40, 63). 
Similarity of E. coli complex I subunits to other bacterial enzymes 
The subunits of complex I resemble subunits found in other bacterial electron 
transfer and proton transporting enzymes (30, 39, 40, 111). The electron transfer moiety 
of complex I is related to three different bacterial enzymes. The first enzyme is a soluble 
NAD+ -reducing hydrogenase encoded by the hox locus in the chemolithotrophic 
bacterium Alcaligenes eutrophus (90, 107). This enzyme is composed of four subunits: a 
(encoded by hoxF), p (encoded by hoxll), y (encoded by hoxU), and 6 (encoded by 
hoxY). Whereas the P/6 dimer is splits H2 (H2➔2H+), the y/6 dimer functions as an 
NADH oxidoreductase (diaphorase; NAD+➔NADH). The a/y dimer also contains an 
FMN prosthetic group and a number of Fe-S clusters. NuoE, NuoF, and NuoG share 
some homology to the a and y subunits whereas NuoB and NuoD share homology with 
the 6 and P subunits (Table 2). The gene order of the hox locus is conserved with respect 
to the corresponding nuo genes. The second enzyme is the hydrogenase 3 of E. coli 
formate hydrogenlyase encoded by the hyc operon (11 ). This enzyme couples the 
oxidation of formate (formate➔CO2) to proton reduction (2H+➔H2). All of the Hye 
subunits share homology with Nuo subunits: HycE is related to NuoC and NuoD; HycG 
is related to NuoB, which also contains an Fe-S center; HycF, a ferrodoxin, is related to 
Nuol, also possessing Fe-S centers; and the membrane proteins HycC and HycD, 
12 
Fig. 2. Schematic of the E. coli complex I and the nuo locus. Adapted with permission 
from T. Friedrich (38, 67, 68, 114). (A) E. coli complex I is comprised of three distinct 
fragments: the peripheral (light gray), connecting (white), and membrane ( dark gray) 
fragments. The peripheral fragment (NDF) is comprised of the nuclear homologs NuoE, 
F, and G and exhibits NADH dehydrogenase activity that oxidizes NADH to NAD+; the 
connecting fragment is comprised of the nuclear homologs NuoB, C, D, and I; and the 
membrane fragment is comprised of the mitochondrial homologs NuoA, H, and J-N and 
catalyzes ubiquinone (Q) to its reduced form (QH2). (B) The E. coli nuo locus encodes 
the fourteen Nuo subunits that constitute complex I. The 5' half of the locus contains a 
previously identified promoter (nuoP) and the majority of genes that encode the 
peripheral and connecting subunits (light gray and white, respectively). The 3' half of the 
locus contains the majority of the genes encoding the membrane subunits (dark gray). 
The 3' end of nuoG encodes a C-terminal region (CTR) of the NuoG subunit (hatched). 
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Table 2. E. coli complex I subunits and their homologs in other bacterial electron 
transfer enzymes and transporters. N-term., N-terminus; C-term., C-terminus; PTS, 
phosphotransferase systems. A. eutrophus, Alca/igenes eutrophus; R. meliloti, Rhizobium 
meliloti. This table is reproduced with permission from T. Friedrich; references for each 
relationship have been reviewed (30, 39, 40, 111 ). 
TABLE 2. E. coli complex I subunits and their homologs in other bacterial electron transfer enzymes and transporters 
E.coli A. eutrophus E. coli formate 
complex I NAD+ -reducing hydrogenlyase hydrogenase 
NuoE a N-term. (HoxF) 
NuoF a C-term. (HoxF) 
NuoG y (HoxU) N-term. 
NuoB o (HoxY) HycG 
NuoC HycE N-term. 
NuoD ~ (HoxH) HycE C-term. 
NuoH HycD 
Nuol HycF 
NuoL HycC 
NuoM 
Bacterial Bacterial R. meliloti 
hydrogenases glucose 
K+/H+ 
dehydrogenases antiporter 
small subunit 
large subunit 
N-term. 
PhaA 
PhaD 
Bacillus C-125 
Na+/H+ 
antiporter 
ORFl 
ORF4 
Bacterial 
PTS 
sugar 
permease 
sugar 
permease 
-VI 
thought to be involved in ubiquinone binding, are similar to NuoL and NuoH, 
respectively {Table 2). In contrast to the hox genes, the hyc genes do not correspond to 
the order of the nuo genes. 
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The third enzyme is bacterial glucose dehydrogenase (glucose:ubiquinone 
oxidoreductases) (74). This family of enzymes catalyzes the oxidation of glucose to 
gluconolactone while reducing ubiquinone (Q➔QH2). They can be inhibited by a number 
of compounds that also inhibit complex I by interfering with its interaction with 
ubiquinone (36, 37). The N-terminus of each of these enzymes is homologous to NuoH 
{Table 2). 
The proton translocating moiety of complex I is related to at least two bacterial 
enzymes, i.e. certain anti porters and phosphoenolpyruvate-dependent phosphotransferase 
systems (PTS). The membrane intrinsic PhaA and PhaD subunits of the Rhizobium 
melioti K+/H+ antiporter share homology with NuoL and NuoM, respectively; likewise, a 
related Na+/H+ antiporter in Bacillus C-125 contains a protein encoded ORFl that shares 
homology with NuoL {Table 2). The pore-forming sugar permeases of the bacterial PTS 
(93) also display some homology to NuoL as well as NuoM {Table 2). 
Evolution of E. coli complex I 
A possible mechanism of evolution of large multisubunit assemblies is that the 
assembly arose by the accretion of its various component activities. This type of modular 
evolution has been described for the bacteriophage lambda and for ATP synthases (18, 
92, 111-113). For the bacteriophage lambda, the genes that encode the head are clustered 
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together and those that encode the tail are clustered together. It has been proposed that 
lambda phages exchange these gene clusters and so evolution is thought to operate at the 
level of the individual functional units, not at the level of the intact virus (18, 92). The 
ATP synthases are comprised of two membrane-bound structural modules, the extrinsic 
F 1 (the ATPase module) and the intrinsic F0 (the proton channel module). The clustering 
of the genes that encode for each module and a conservation of gene order in various 
organisms support modular evolution for this enzyme complex as well (112, 113). 
The nuo genes are also clustered and their arrangement is conserved (refer to the 
"E. coli complex I and nuo Locus" section above). And, E. coli complex I is similar to a 
number of other bacterial enzymes. These pieces of data are consistent with the 
possibility that E. coli complex I has evolved by fusion of preexisting modules for 
electron transfer and proton translocation (30, 35, 39, 40, 111, 116). 
The E. coli complex I is believed to have evolved first from a hydrogenase 
(NuoB, NuoD), a ferrodoxin (Nuol), a transport protein (NuoM), a protein possessing a 
quinone reduction site (NuoH), and a protein of unknown function (NuoC). A triplication 
event of NuoM created NuoN and NuoL within the complex. The enzyme that resulted 
was a common ancestor of complex I and formate hydrogenlyase. It likely used H2 as an 
electron donor working through NuoB-D and Nuol, while NuoL-N functioned in proton 
translocation, and NuoH served as the ubiquinone-binding site. A more sophisticated 
H2::quinone oxidoreductase evolved upon the acquisition ofNuoA, NuoJ, and NuoK 
(whose functions are unknown). Later in evolution, this primitive enzyme complex 
acquired the NADH dehydrogenase component (NuoE, NuoF, NuoG) which resulted in 
complex I, an NADH:ubiquinone oxidoreductase. 
Assembly of complex I 
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In the fungus Neurospora crassa, cells assemble complete complex I en bloc from 
two independently assembled subcomplexes. Once both subcomplexes (arms) are 
formed, they assemble into a single enzyme complex at the mitochondrial matrix (31, 34, 
81, 98, 108), presumably through the actions of accessory proteins (111). The peripheral 
arm, comprised of only nuclear-encoded subunits, assembles independently of the 
membrane arm in cells grown in the presence of chloramphenicol, an antibiotic that 
inhibits mitochondrial protein synthesis (34). The membrane arm, comprised of both 
nuclear- and mitochondrial-encoded subunits, also assembles independently by cells 
grown under Mn+2-limiting conditions, a condition that prevents the synthesis of the 
peripheral arm (98). Accumulation of either arm occurs even if a subunit from one arm 
is genetically disrupted (25, 31, 41, 54, 57, 81, 100). 
The similarity of complex I in E. coli to the N. crassa enzyme in terms of 
evolution and subunit functionality suggests that the E. coli and N. crassa enzymes may 
also share similar modes of assembly (38-40, 68). The organization of the nuo locus is 
consistent with the hypothesis that E. coli complex I assembly also proceeds first by 
constructing independently assembled subcomplexes (38, 68). Perhaps, throughout the 
evolution of complex I, regulatory components of each protein assembly remained within 
the nuo locus to coordinate regulation of its two halves, ensuring proper assembly of a 
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complete and functional complex I. Since E. coli harbors all of its nuo components in a 
single cellular compartment, the regulation of expression and assembly would, however, 
differ between E. coli and eukaryotes. 
Regulation of nuo by External Regulators 
Many components of the respiratory chain are known to be extensively regulated 
at the level of transcription. In response to various electron donors and electron 
acceptors, global transcriptional regulators (FNR, NarL, and ArcA) coordinately regulate 
the expression of the dehydrogenases and terminal reductases of the respiratory chains 
( 48, 60, 109). 
An extensive examination of the effect of external regulators on nuo transcription 
in E.coli was performed by Bongaerts et al. (12) and Tran et al. (106). The first study 
examined the role of electron acceptors, electron donors, and global transcriptional 
regulators on nuo transcriptional control, while the second study focused on nuo 
expression during formate respiration. These researchers determined that the electron 
acceptors 0 2 and nitrate induce nuo transcription via the regulators ArcA, NarL, FNR, 
and IHF. In contrast, cAMP-CRP seemed not to be involved. ArcA acted as a strong 
repressor during anoxic conditions. NarL acted as a strong activator under the anoxic 
conditions in the presence of nitrate. The global regulators FNR and IHF behaved as 
weak repressors, exerting little effect on nuo transcription under anaerobic conditions. 
This pattern of expression differs from that of ndh; ndh is primarily regulated by FNR 
(44). Additionally, the electron acceptor fumarate (via an unknown mechanism) served 
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to increase nuo expression anaerobically. In terms of electron donors, nuo transcription 
was increased aerobically by C4 dicarboxylates (e.g. succinate, fumarate, and malate) and 
acetate. Growth on substrates supplying high levels ofNADH, e.g. glucose or glycerol, 
however, did not stimulate nuo expression either aerobically or anaerobically. 
Furthermore, a comparison of operon and protein fusions demonstrated that the 
expression of nuo is regulated at the level of transcription, not translation, by electron 
donors and acceptors. 
It is likely that E. coli possesses both its NADH dehydrogenases to effectively 
maintain a redox balance in the cell (12, 16, 35, 52, 106) and to maximize energy 
production/conservation (12, 16). nuo is expressed in the presence of many electron 
donors and acceptors under both aerobic and anoxic conditions (12, 106), whereas ndh is 
expressed primarily under aerobic conditions (44, 104). Both are repressed during 
fermentation, when NADH cannot be reoxidized (12). It has been proposed that cells 
may regulate the NADH/NAD+ levels in the cell and the amount of energy recovered 
from NADH oxidation by controlling the relative levels and/or activities of the two 
NADH dehydrogenases (16). Additionally, the presence of multiple NADH 
dehydrogenases in E. coli, as well as other dehydrogenases, allows the cell to modulate 
the electron flow through its respiratory chains in response to its environment (106, 109). 
nuo promoter elements 
Putative 0 70-dependent -35/-10 sites were identified within the nuo promoter 
region for E. coli (12, 114) and a -10 site was described in S. typhimurium (3). However, 
21 
these sites were described as poor consensus sequences. Furthermore, in the study 
performed by Bongaerts et al. (12), primer extension experiments revealed two 
transcriptional start sites: one close to the start site described previously by Weidner et al. 
(114) and a more distal site located at -173/-172. Additionally, two distinct regulatory 
regions were defined. A proximal promoter region was shown to be required for 
regulation by 0 2 and nitrate and the global regulators ArcA, NarL, and FNR, whereas a 
distal promoter region was shown to be required for transcriptional stimulation by C4 
carboxylates and acetate. These findings suggest that the nuo operon may possess more 
than one promoter upstream of nuoA. 
Defects in complex I 
Defects in bacterial complex I cause pleiotropic phenotypes. In E. coli and/or S. 
typhimurium, the defects affect the ability of cells to perform chemotaxis (91 ), to grow on 
certain carbon sources (4, 8, 16, 91, 124), to survive stationary phase (126), to perform 
energy-dependent proteolysis (4), to regulate the expression of the dnaN gene (75), and 
maintain virulence ( 6). In Rhodobacter capsulatus, the defects prevent cells from 
growing photosynthetically under anaerobiosis (28); while in Myxococcus xanthus, the 
defects cause cells to halt the production of extracellular proteins and to fail to develop 
and sporulate properly (66). 
Defects in eukaryotic complex I also elicit severe physiological consequences. In 
the fungi Neurospora crassa and Aspergillus niger, defects in complex I have been 
shown to cause a number of defects, including a reduction in growth rate ( 1, 31, 54, 81, 
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115) and poor conidiation (54). In humans, complex I defects are associated with 
idiopathic Parkinson's disease, Leber's Hereditary Optic Neuropathy, and other severe 
neuromuscular degenerative diseases (9, 13, 96, 99). These diseases predominately affect 
brain and muscle, organs with the highest demand for ATP (116). Furthermore, complex 
I deficiency has also been shown to play an important role in the aging process (21, 86, 
89) and perhaps even in drug addiction (22). Since eukaryotic mitochondrial complex I 
consists of 40-50 subunits, its size and complexity make it the least understood proton 
translocating complex. This lack of understanding hampers efforts to define the role that 
defects in complex I play in human disease. 
CHAPTER II 
MATERIALS AND EXPERIMENTAL METHODS 
Chemical and Biological Reagents 
Restriction enzymes were purchased from Promega Corporation (Madison, WI), 
Gibco-BRL Life Technologies (Gaithersburg, MD), or New England BioLabs (Beverly, 
MA). Antibiotics were purchased from Sigma Chemical Company (St. Louis, MO). 
Enzymes and substrates were obtained from Boehringer Mannheim (Indianapolis, IN) or 
Sigma Chemical Company. Radiolabeled materials were purchased from Amersham 
(Arlington Heights, IL) and the bicinchoninic acid (BCA) protein assay reagent was 
obtained from Pierce Biochemicals (Rockford, IL). 
Bacterial Strains and Mutant Alleles 
All strains are derivatives of E. coli K-12 and are listed in Table 3. The llnuoGJ 
and nuoG2 mutant alleles were constructed by first subcloning a 7.0-kb EcoRI-PstI nuo 
fragment from pAJW105/lPstI, a plasmid that encompasses the 3' end of nuoFto the 3' 
end of nuoL (refer to Fig. 5), into the site-directed mutagenesis vector pAL TER 
(Promega Corporation, Madison, WI). Then, following the manufacturer's instructions, 
two rounds of site-directed mutagenesis were performed using the primers CTRl 
(5'-GTTTGGCAGCGATGAGTCGACACAGCGTGCTCCGG-3') and CTR2 
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TABLE 3. Bacterial strains used in this study 
Strain Relevant genotype Source 
or reference 
Wild-we: 
CP366 po!A(Ts) thi-1 thr(am)-1 leuB6 (50, 87) 
hisF-4 rpsLJ 36a lac Yi xyl-5 aral 4 
tonA31 tsx-78 rha zig::Tnl(l- Ace-
CP875 thi-1 thr(am)-1 leuB6 hisF-4 (91) 
rpsL13~ lacYJ A.lacX74 AlacY 
K-12 prototrophic wild-type ATCC #23716 
Nuo mutants: 
AJW844 CP875 nuoB::Km MCN021 X CP875➔KmR Nuo-
AJW853 CP875 nuoB-C::Cmb MWC230 X CP875➔CmR Nuo-
AJW851 CP875 nuoF::miniTnJ0Cmc ZK1363 X CP875➔CmR Nuo-
CP938 CP875 A.(nuoF-L)-1 (91) 
CP910 CP875 nuoG::Tnl0-la (91) 
CP932 CP366 nuoG: :Tnl 0-1 a (91) 
AJW931 CP366 A.nuoG Jd This study 
AJW1516 CP875 A.nuoGJd This study 
AJW1470 CP366 nuoG2e This study 
AJW1517 CP875 nuoG2e This study 
AJW845 CP875 nuoH::Km NDl-KanR X CP875➔KmR Nuo-
AJW846 CP875 nuol::Km MCN091 X CP875➔KmR Nuo-
AJW852 CP875 nuoM::miniTnlOCmc ZK1362 X CP875➔CmR Nuo-
AJW847 CP875 nuoN::Km ANN141 X CP875➔KmR Nuo-
AJW932 CP366 pHFl 7r integrate This study 
AJW1459 AJW931 pAJWl 05.6...Pstlg integrate This study 
AJW1472 AJW1470 pAJW105A...Pstlg integrate This study 
Strain Relevant genotype Source 
or reference 
AJW1567 CP875.1nuoG Jd This study 
nuoM: :miniTnl 0Cmc 
AJW1568 CP875 .1nuoGJd nuoN::Km This study 
AJW1569 CP875 nuoG2e This study 
nuoM: :miniTnl 0Cmc 
AJW1580 CP875 nuoB::Km This study 
nuoF: :miniTnl 0Cmc 
AJW1581 CP875 nuoB: :Km nuoB-C: :Cmb This study 
AJW1582 CP875 .1nuoGJd nuoH::Km This study 
AJW1583 CP875 .1nuoGJd nuo/::Km This study 
AJW1584 CP875 nuoG? nuoH::K.m This study 
MCN021 nuoB::Km (10) 
MWC230 nuoB-C: :Cmb R. Gennis 
ZK1363 nuoF: :miniTnl 0Cmc (126) 
NDl-KanR nuoH::Km (10) 
MCN091 nuol::Km (10) 
ZK1362 nuoM: :miniTnl 0Cmc (126) 
ANN141 nuoN::K.m (10) 
Sigma factor mutants: 
UQ285 
AJW1015 
AJW1409 
ZKlO00 
F- re/A+ stA+ argG lac thi [ A cl857 
h80 st68 dlac+] rpoD(Ts); 
RpoD(o70?s 
(123) 
CP875 rpoS(katF)::Km; RpoS(os138} ZKlO00 X CP875➔KmR 
CP875 rpoN::TnJ0-P; RpoN(oN154} YMC18 X CP875➔TcR 
rpoS(katF)::Km R. Kolter 
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Strain Relevant genotype Source 
or reference 
YMC18 rpoN: :Tnl 0-1 a A. Ninfa 
Others: 
AJW803 CP875 .dacsA::Km S. Kumari 
a nuoG::TnJ0-1 and zig::TnJO confer Tell; rpsLJ 36 confers Str8-. 
b The Cm cassette is located in the intergenic region between nuoB and nuoC. 
c These mutations have been renamed to reflect their location within the nuo locus. 
d The dnuoGI mutation is a 235-bp deletion of a 3' region of nuoG. 
e The nuoG2 mutation is a 235-bp tandem duplication of a 3' region of nuoG. 
rpHFl 7 confers ApR and carries the dnuoGJ allele. 
gpAJW105APstI confers ApR and carries the wild-type nuoG allele. 
(5'-GCGCGCATCTTGAGGTCGACAAGGAGGCACAACAA-3'), to create two 
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unique San sites flanking the 3' region of nuoG that encodes a C-terminal region (CTR) 
of the NuoG subunit. Next, these sites were used for cloning purposes to construct one 
plasmid (pHFl 7) that harbored a 235-bp deletion of the CTR (allele .dnuoGJ) and one 
plasmid (pHF18) that harbored a 235-bp tandem duplication of the CTR (allele nuoG2). 
HindIII fragments from pHF 1 7 and pHF 18 were subsequently subcloned into the 
temperature-sensitive suicide vector pMAK.705 (52) to yield plasmids pHF68 and pHF69, 
respectively. Finally, alleles .dnuoGI and nuoG2 were introduced into the chromosome 
(Fig. 3) by means of homologous recombination following transformation with i) 
plasmids pHFl 7 and pHF18, respectively, into the Nuo+ PolATs host strain CP366 (50, 
87) or ii) plasmids pHF68 and pHF69, respectively, into the closely related Nuo+ strain 
CP875 (52). Resultant recombinants were screened for the .dnuoGJ deletion or the 
nuoG2 duplication by whole-cell PCR (94) using primers GI (5'-
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TTGGCGATCCGGGCGTGC-3') and Hl (5'-CAACCACCCAACCCGGAC-3') that 
flank the nuoG CTR (Fig. 3). The wild-type nuoG allele produced a 717-bp product, the 
ll.nuoGJ allele produced a 482-bp product, and the nuoG2 allele produced a 952-bp 
product (Fig. 4). One CP366 ll.nuoG 1 recombinant ( designated strain AJW931 ), one 
CP366 nuoG2 recombinant (AJW1470), one CP875 ll.nuoGJ recombinant (AJW1516), 
and one CP875 nuoG2 recombinant (AJW1517) were selected for further study. The nuo 
mutant strains CP910 (allele nuoG::Tnl0-l) and CP938 (ll.(nuoF-L)-l) are derivatives of 
the nuo wild-type strain CP875, while CP932 (nuoG::Tnl0-l) is a derivative of the wild-
type strain CP366 (91). To add to this isogenic set of nuo mutants, generalized 
transduction, using the phage Plkc (101), or transformation using chromosomal DNA 
was used to transfer mutant nuo alleles from a variety of genetic backgrounds (10, 43, 
126) into strain CP875. The location of the nuoB::Km mutation (strain AJW844) relative 
to that of mutations nuoB-C::Cm and nuoF::miniTnl0Cm was verified genetically 
(97.4% and 70.8% linkage, respectively) and confirmed by Southern blot analysis (data 
not shown). 
A strain carrying both the wild-type and ll.nuoG 1 alleles on its chromosome was 
isolated following an integrative, homologous recombination event by the Campbell-type 
mechanism (88, 125) between pAJW105APstl, which carries the wild-type nuoG allele, 
and the ll.nuoGJ po/A(Ts) strain AJW931 (Fig. 5). Following transformation and a shift 
in temperature from 32 °C to 42 °C, a single, non-reciprocal, homologous recombination 
event between the cloned insert in pAJWl 05APstI and the nuo locus in AJW931 resulted 
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Fig. 3. Wild-type nuoG and mutant ll.nuoGJ and nuoG2 alleles. + 1, nuo transcription 
initiation site (114). Restriction enzyme sites: E, EcoRI; P, Pstl; S, San derived by site-
directed mutagenesis to facilitate construction of mutant alleles. CTR (hatched), a 235-bp 
3' region of nuoG present in the wild-type nuoG, deleted in the ll.nuoG 1 allele, and 
duplicated in tandem in the nuoG2 allele. Inverted triangle, location of the CTR deletion. 
Gland Hl, flanking primers used to amplify CTR. 
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Fig. 4. Products of PCR amplification to confirm the mutant anuoGJ and nuoG2 
alleles. PCR was performed with plasmid or chromosomal DNA as described in 
Materials and Experimental Methods using primers G 1 and Hl (see Fig. 3). The 
products were electrophoresed on a 1.8% agarose gel containing 10 µg/ml EtBr. 
Expected product sizes: wild-type nuoG allele, 717-bp; anuoGJ allele, 482-bp; nuoG2 
allele, 952-bp. Markings on the left indicate the sizes of the <l>Xl 74 Haem DNA 
marker (Gibco-BRL; marker sizes: 1350-bp, 1080-bp, 870-bp, 600-bp, 310-bp). Lanes 
are as marked. 
in a partial, non-tandem duplication of the nuo locus at either end of the vector sequence 
(50, 87). The resultant strain was designated AJW1459. A similar strain (AJW932) was 
constructed when the plasmid pHFl 7, which carries the mutant anuoGJ allele, was 
integrated into the Nuo+ Po IA Ts strain CP366 in the same manner. Likewise, a strain 
(AJW1472) carrying both the wild-type nuoG and mutant nuoG2 alleles on its 
chromosome was constructed when the plasmid pAJWl 05LV>stl was integrated into the 
nuoG2 polA(Ts) strain AJW1470. Maintenance of integration was verified following each 
experiment by confirming the vector-encoded ampicillin resistance of each strain at 42 °C 
(50) and the concurrent presence of both the wild-type nuoG and anuoGJ or nuoG2 
alleles within the chromosome by PCR analysis using primers G 1 and Hl . 
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Fig. 5. Construction of the cointegrate strain by integrational, homologous 
recombination. Vector-derived nuo sequence (white); chromosome-derived nuo 
sequence (gray); vector sequence ( dotted line); ampicillin resistance, ApR. Other 
designations as in Fig. 3 legend. The plasmid pAJW105Mstl encompasses the 3' end of 
nuoFto the 3' end of nuoL and carries the wild-type nuoG allele. This plasmid was 
transformed into competent AJW931 (llnuoGJ po/A(Ts)) cells. Cells in which the 
plasmid had integrated into the chromosome by homologous recombination were 
identified by selection for ampicillin resistance at the restrictive temperature, 42 °C. Not 
shown: Strain AJW932 was constructed similarly, except that the plasmid pHFl 7, which 
carries the llnuoGJ allele, was integrated into the Nuo+ PolATs strain CP366. Strain 
AJW1472 was constructed in a similar manner by integrating pAJW105Mstl into strain 
AJW1470 (nuoG2 po/A(Ts)). The concurrent presence of both the wild-type and mutant 
nuoG alleles in each of these strains was verified by PCR analysis with primers G 1 and 
Hl. 
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Media and Growth Conditions 
Cells were grown with aeration in tryptone broth (TB), composed of 1 % (wt/vol) 
tryptone and 0.5% (wt/vol) sodium chloride, or in Luria-Bertani media (LB), composed 
of TB and 0.5% (wt/vol) yeast extract (78). When necessary, 100 µg/ml ampicillin, 15 
µg/ml tetracycline, 34 µg/ml chloramphenicol, or 40 µg/ml kanamycin was added. Cells 
were grown at 32 °C, unless otherwise stated. To obtain growth curves, cells were grown 
in LB (supplemented with the appropriate antibiotics) to mid-exponential phase (0D610 
0.35-0.4), then diluted 10-2 into fresh TB (without antibiotics), and aerated until they 
reached stationary phase. To obtain samples for p-galactosidase assays, cells were grown 
the same as for growth curves and samples were removed at the indicated time points. To 
test for the ability to use acetate as the sole carbon source, cells were grown in TB at 
32 °C to mid-exponential phase prior to harvesting and resuspension at 10-5 (vol of 100 
µl). 50 µl of the diluted culture was spread on M63 minimal media plates (91, 101) 
supplemented with 25 mM sodium acetate (pH 7.0). Each plate was incubated at 32°C 
for 55.5 h. When whole cell lysates were required, cells were harvested by centrifugation 
at 3500 x g for 10 min at 4 °C, washed once with phosphate-buffered saline (PBS), and 
lysed by sonication. 100 µl of the whole cell lysate was used to determine either the total 
protein concentration of each sample by the BCA reagent method of Smith et al.1985, 
using bovine serum albumin (BSA) as a standard (103) (Pierce, Rockford, IL), or to 
perform P-galactosidase assays described below. 
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Swarm Assays 
Cells were aerated in TB supplemented with the appropriate antibiotics at 32·0 c to 
mid-exponential phase (OD610=0.35-0.4). Tryptone swarm plates were 0.25% agar in the 
same media. Antibiotics were not added. A 5 µl aliquot (106 to 107 cells) was inoculated 
at the center of the surface of each swarm plate. Swarm plates were incubated at 32 °C in 
a humid environment until the outermost, serine ring reached the edge of the petri plate 
(117). The plates were then examined for the presence of the inner, aspartate ring (117). 
The absence of this inner ring was taken as indicative of the Nuo- phenotype, i.e. the lack 
of functional complex I (91 ). 
Plasmid and Chromosomal DNA Preparation 
Plasmid preparations were performed according to the alkaline lysis procedure 
(95), using either the Promega Wizard Miniprep Purification System (Madison, WI) or 
the QIAGEN plasmid midiprep kit (Santa Clarita, CA). Chromosomal DNA was 
prepared as described (83) based on the principle of salting-out proteins. Cells grown in 
3 ml LB were harvested, washed lX in PBS, resuspended in 1 ml SET buffer (75 mM 
NaCl, 25 mM EDTA, 20 mM Tris-HCl [pH 7.5]), and lysed in the presence of 1 mg/ml 
lysozyme. Preparations were incubated at 37°C for 0.5 h, and then incubated at 55°C for 
1 h treated with 0.1 vol of 10% SDS and 1 mg/ml proteinase K. Cellular proteins were 
precipitated by the addition of 0.33 vol of 5 M NaCl and 1 vol chloroform followed by 
incubation for 30 min at RT on a rotating vertical wheel. The chromosomal DNA was 
precipitated from the aqueous phase by the addition of 1 vol isopropanol followed by 
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centrifugation at 3,200 x g for 5 min. The DNA was washed IX in 70% ethanol, dried, 
and dissolved in dH2O. DNA concentrations, estimated by UV spectrophotometric 
determinations, were calculated by the formula: concentration (mg/ml)= A260/20. 
Transformation of Competent E. coli 
To make cells of E. coli strains competent, they were grown in 5 ml cultures of 
YB media (2% Bacto-typtone, 0.5% Bacto-yeast extract, 0.5% MgSO4, adjusted to pH 
7.6 with KOH) at 37°C under aeration until OD610=0.3. Cells were diluted 1:20 into fresh 
prewarmed YB media grown under identical conditions until OD610=0.46, chilled for 5 
min on ice, and centrifuged (5 min, 4 °C, at 3,200 x g). The supernatants were decanted, 
cell pellets were resuspended in ice-cold Tbfl solution (30 mM potassium acetate, 100 
mM KCl, 10 mM CaC12, 50 mM MnC12, and 15% [vol/vol] glycerol, adjusted to pH 5.8 
with acetic acid), and chilled on ice for 5 min. Cells were again pelleted by 
centrifugation, supernatants decanted, cell pellets resuspended in ice-cold Tbf2 (10 mM 
MOPS, 75 mM CaC12, 10 mM KCl, and 15% (vol/vol) glycerol, adjusted to pH 6.5 with 
KOH), and chilled on ice for 15 min. Aliquots of frozen competent cells were stored at -
70°C following freezing in an isopropanol/dry ice bath. Plasmid transformations with 
competent cells were performed as described (53, 95, 101) by gently mixing a 50 µl 
aliquot of thawed competent cells and 1-3 µl of plasmid DNA (1-10 ng) in a 15 ml round-
bottom polypropylene tube. Contents were incubated on ice for 5 min, followed by a 
heat-shock pulse at 42 °C for 60 s, and placed on ice for 2 min. LB supplemented with 
0.25% glucose was added to transformed cells. These cells were allowed to express their 
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respective antibiotic resistance( s) during a 1 h incubation before being plated onto 
selective media and incubated ON. Chromosomal transformations were performed with 
chromosomal DNA (~0.1 µg- 1.0 µg) from nuo mutant cells and transformed into 
competent cells. 
Generalized Transduction 
Generalized transduction involved the use of P lkc (101 ). Donor phage lysates 
were prepared by inoculating single colonies into 5 ml of LB and grown with aeration at 
37°C ON. 50 µl of ON cultures were inoculated into two tubes containing fresh LB 
media (5 ml, each supplemented with 0.2% D-glucose and 5 mM CaC12); to one tube no 
phage was added (control); and to the other 100 µl of Pl phage lysate (grown on the 
ATCC strain K-12) was added. Growth with aeration at 37°C continued until lysis was 
complete. Lysates were clarified by the addition of 100 µl chloroform followed by 
centrifugation at 3,000 x g for 15 min. Recipients cells were prepared by diluting ON 
cultures into fresh LB media (supplemented with 0.1 % o-glucose and 10 mM CaC12) with 
an initial OD610=0.02-0.04. These cultures were aerated at 37°C until they reached an 
OD610=0.4-0.6. Cells were then infected with 0, 10, or 100 µl donor lysate and incubated 
without aeration for 20 min at 37°C. To prevent phage readsorption, 200 µl of 1 M 
sodium citrate was added, the cells centrifuged, and the resultant pellets resuspended in 
500 µl LB supplemented with 250 mM sodium citrate. The cells were then incubated at 
37°C for 1 h to allow for expression, centrifuged, resuspended in 100 µl of lM sodium 
citrate, and plated onto appropriate selection media. Transductions involving donor 
and/or recipient strains that carried the po/A(Ts) allele were grown at the permissive 
temperature of32°C. 
Cloning and Restriction Endonuclease Analysis 
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Restriction endonuclease digestions of chromosomal or plasmid DNA were 
performed according to the manufacturers' specifications and as described (95). Digested 
DNA fragments were electrophoretically separated on agarose gels 0.8%-2.0% (wt/vol) in 
lX TAE buffer (40 mM Tris-acetate, 1 mM EDTA). Fragments< 500 bp were purified 
with the Wizard PCR Prep Purification System (Promega); larger fragments were 
purified by treating agarose pieces with 1.5 vol of 6 M NaCl followed by incubation at 
50°C for 15 min, and purification of DNA with the Promega Wizard Miniprep 
Purification System. Cohesive-end ligation of DNA fragments was performed as 
described (95). Vector arms were usually dephosphorylated at 5' termini using calf 
intestinal alkaline phosphatase (Gibco-BRL) according to manufacturer's instructions. 
Polymerase Chain Reaction 
Either plasmid DNA or chromosomal DNA was used as a template for the 
polymerase chain reaction (PCR). To amplify products 200-bp to 1.2-kb in length, each 
PCR, performed in a 100 µl volume, contained template ( ~ 10 ng plasmid DNA or ~ 100 
ng chromosomal DNA), primers (0.1 m. each), deoxynucleoside triphosphates (0.2 mM 
each), MgC12 (2.0 mM), PCR buffer (20 mM TrisHCl and 50 mM KCl), and 2.0 U Taq 
DNA polymerase (Gibco-BRL). The PCR was performed in an Perkin-Elmer 9600 
., 
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Thermal Cycler (Foster City, CA) for 40 cycles. Each cycle consisted of denaturation at 
94 °C for 30 sec, annealing for 1 min at 55 °C, and extension for 1 min at 72 °C. A final 
5 min extension step at 72 °C was employed. 
Long-distance PCR, using the Advantage KlenTaq Polymerase Mix (Clontech 
Laboratories, Palo Alto, CA), was employed to amplify fragments > 1.2-kb. Each PCR, 
performed in a 50 µ1 volume, contained ~ 100 ng chromosomal DNA as template, primers 
( 400 nM each), dNTPs (0.25 mM each), KlenTaq PCR reaction buffer [ 40 mM Tricine-
KOH, pH9.2@25°C; 15 mM KOAc; 3.5 mM Mg(OAc)2; 75 µg/ml BSA; and IX 
KlenTaq Polymerase Mix (KlenTaq-1 DNA polymerase, Deep Vent DNA polymerase, 
and TaqStart antibody (1.1 µg/µ1) in storage buffer)]. The PCR was carried out in a 
Perkin-Elmer 9600 Thermal Cycler using the following profile: 1 cycle, 94 °C, 1 min; 30 
cycles, 95°C 15 s, 55°C 30 s, 68°C 6 min; 1 cycle, 68°C, 6 min; soak at 4°C . 
RNA Extraction 
Total cellular RNA was extracted from cells grown in TB at 32 °C to mid-
exponential phase (OD610=0.35-0.4) using the RNeasy mini prep kit columns according to 
the manufacturer's instructions (QIAGEN). Prior to quantification, RNA samples were 
subjected to DNasel (1 U/µg; RQl RNase-free DNasel; Promega) and purified using 
RN easy columns. The RNA concentration and purity were estimated by measuring the 
A260 and A280 of the solution on a DU460 spectrophotometer (Beckman). 
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Dot Blot and Northern Blot Analyses 
For dot blot analysis, 0.5 µg RNA from each strain was directly transferred to 
multiple GeneScreen Plus nitrocellulose membranes (NEN Life Science Products, 
Boston, MA), using the Schleicher and Schuell (Keene, NH) dot blot apparatus according 
to the manufacturers' instructions. The RNA was both heat- and UV-fixed to the 
membranes. The resultant RNA dot blots were prehybridized at 42°C in the presence of 
denatured, salmon or herring sperm DNA for 2-6 h in a buffer comprised of 5X SSC, 
50% (w/v) deionized formamide, 5X Denhardt's solution, 1 % SDS, and 10% dextran 
sulfate (Na salt). Hybridization was performed for 16-28 h in the same buffer, except that 
the nonhomologous DNA was excluded. DNA probes labeled with [ a- 32P]dCTP using 
the RTS RadPrime DNA labeling system (Gibco BRL) were added to the hybridization 
solution following denaturing. The membranes were washed as per the manufacturer's 
instructions before autoradiography with Kodak XAR film (New Haven, CT) at -70°C 
for 8 days. 
For northern blot analysis, 5 µg of total RNA was denatured at 65°C for 15 min in 
the presence of 2M formaldehyde, 50% formaldehyde, and lX MOPS then 
electrophoresed on a 1 % agarose gel containing 2M formaldehyde and 50% formamide in 
lX MOPS running buffer. 3 µl of 1 mg/ml EtBr was added directly to each RNA sample 
prior to electrophoresis. Following electrophoresis, the RNA was transferred by capillary 
action to a GeneScreen Plus nitrocellulose membrane (NEN Life Science Products) as 
described by the manufacturer. The RNA was both heat- and UV-fixed to the membrane. 
Prehybridization, hybridization, washing, probing, and autoradiography were all 
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performed as described for the RNA dot blots. Stripping of the probe was performed by 
boiling the membranes in a solution of 2% SDS and 2X SSC for 10 min. Stripping was 
verified by autoradiography. 
SDS-PAGE and Immunoblot Analysis 
Total whole cell lysate protein (100 µg) and/or purified complex I (a gift from T. 
Friedrich) were loaded onto 7 .5% polyacrylamide gels in the presence of 0.1 % SDS ( 65) 
and subjected to a voltage of300 V, using a SE600 protein gel apparatus (Hoefer 
Scientific Instruments, San Francisco, CA), until the loading dye was about 1 cm from 
the bottom. The proteins were transferred electrophoretically overnight to 0.45 µm 
nitrocellulose membranes using a Trans-Blot Cell apparatus (Bio-Rad Laboratories, 
Richmond, CA). The membranes were blocked with 5% w/v nonfat dried milk in TBST, 
composed of20 mM Tris-HCl (pH 7.6), 150 mM NaCl, and 0.1 % Tween 20, for 2 hat 
room temperature. They were washed for 5 min in TBST before being subjected to 
sequential incubation with rabbit anti-£. coli complex I polyclonal antibody #2409 (also a 
gift from T. Friedrich) for 2 hat room temperature and goat anti-rabbit lgG (heavy and 
light chain specific) alkaline phosphatase-conjugated antibody at appropriate dilutions for 
2 hat room temperature. Finally, they were washed three times for 5 min each in TBST 
between each incubation step. Color development was achieved with nitroblue 
tetrazolium and 5-bromo-4-chloro-3-indoylphosphate as described (55). 
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Fig. 6. Operon fusion vector. pHF9, a multi-copy nuoPA '::lacZYA transcriptional 
(operon) reporter fusion constructed from pRS415 (102). The 443-bp nuo insert 
consists of the nuo promoter (114) and the proximal third of nuoA. ApR, ampicillin 
resistance; Tl4, transcriptional terminator; trpA', trp operon sequence; lacZYA, lac 
operon including its translational machinery but missing the lac promoter. 
Reporter Fusion Construction and P-galactosidase assays 
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For studies examining the role of nuo mutations on nuo promoter activity, a multi-
copy nuoPA'::lacZYA reporter fusion was constructed by subcloning a 443-bp fragment 
of plasmid pNUO2.3 (114) that encompasses the nuo promoter (nuoP) and the proximal 
third of the nuoA gene into pRS415, an operon (transcriptional) fusion vector (102). The 
resultant plasmid, pHF9 (Fig. 6), was transformed into both wild-type and nuo mutant 
cells and the P-galactosidase activity of the transformants quantified as a measure of nuo 
promoter activity (17, 102). P-galactosidase activity was determined in an ONPG assay 
according to the procedure of Miller (78) and the Sigma Chemical Co. (St. Louis, MO), 
except that the cells were disrupted by sonication, centrifuged at 12,000 rpm for 5 min, 
and the initial rate of reaction was measured. The protein concentration was determined 
by the BCA reagent method (103). p-galactosidase activity is expressed in terms of 
specific activity (sp act; U/mg, where U=µmol ONP formed/min). Determination of both 
protein concentration and p-galactosidase activity was performed using a DU640 
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Fig. 7. Protein fusion vectors. pHF13 and pHF14, multi-copy nuo::lacZYA 
translational (protein) reporter fusions constructed from pRS414 (102). pHF13, the 
short fusion, is analogous to pHF9 in that it contains a 443-bp nuo insert consisting of 
the nuo promoter and the proximal third of nuoA. However, pHF14, the long fusion, 
contains a 992-bp nuo insert consisting of the nuo promoter, the entire nuoA gene, and 
the proximal third of nuoB. ApR, ampicillin resistance; T1 4, transcriptional 
terminator; trpA ', trp operon sequence; lac 'ZYA, lac operon excluding its 
transcriptional and translational machinery and the first seven codons of lacZ. 
spectrophotometer (Beckman). For studies involving nuo::lacZYA protein (translational) 
fusions, two multi-copy reporter constructs were made. These constructs differed from 
pHF9, the operon fusion described previously. Both protein fusions lack the lac 
translational machinery present in the operon fusion: instead they utilize nuo translational 
machinery. One protein fusion, analogous to the operon fusion, was constructed by 
subcloning a 443-bp fragment of plasmid pNUO2.3 (114) that encompasses the nuo 
promoter (nuoP) and the proximal third of the nuoA gene into pRS414, a protein 
(translational) fusion vector (102). The second fusion was constructed by subcloning a 
larger 992-bp fragment ofpNUO2.3 that encompasses the nuo promoter (nuoP), all of the 
nuoA gene, and the proximal third of the nuoB gene into pRS414. The resultant multi-
copy fusions were designated pHF13 (the short fusion) and pHF14 (the long fusion), 
respectively (Fig. 7). 
Expression Constructs 
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The genes nuoH-Nwere amplified from the chromosome ofCP875 (wild-type) by 
PCR using the high fidelity polymerase mixture Advantage KlenTaq Polymerase Mix 
(Clontech Laboratories) and the primer G15 (5'-CACGCGTCTACATTAGTTACG-3'), 
which lies 157-bp upstream of the nuoH start site, and primer N3 
(5'-TAACGCTCTAGATCTATCTAC-3'), which lies 86-bp downstream ofnuoN. The 
resultant amplification product was 7539-bp and contained unique Xbal sites flanking the 
ends which were introduced by the primers. The Xbal sites were used to clone the 
product into the expression vector pBAD33 (51) (Fig. 8). Since it is a pACYC184-
derived vector, pBAD33 is compatible with ColEl-derived vectors (such as pRS415, the 
operon fusion vector). The cloning was not directional, therefore two constructs were 
generated: one in which the nuo genes were oriented such that they would be transcribed 
from the P8 AD promoter and one in which the nuo genes were oriented opposite the P8 AD 
promoter. These constructs were designated pHF78 and pHF79, respectively. Either 
pBAD33 vector, pHF78, or pHF79 were transformed into wild-type cells (CP875) along 
with pHF9 (the nuoPA '::/acZYA operon fusion). Single transformants and double 
transformants were selected for by the appropriate antibiotic resistance(s) on LB plates 
containing the chromogenic indicator X-gal (40 µg/ml) and L(+)-arabinose (0.05%) as an 
inducer of PeAD· Subsequently, the transformants were grown in TB at 32°C in the 
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Fig. 8. pBAD33:nuo expression constructs. pHF78 and pHF79, multi-copy 
expression plasmids constructed from the pACYC184-derived, arabinose-inducible 
vector, pBAD33 (50). araC, co-inducer of the ara operon; P8AD, the arabinose-
inducible promoter of the ara operon; 5S and rrnBT12, parts of the 5S rRNA and the 
strong rrnB terminators, respectively; bla', truncated P-lactamase gene; cat, 
chloramphenicol acetyltransferase gene encoding Cm resistance. The 7539-bp nuoH-N 
insert was cloned either in the same orientation as P8AD or in the opposite orientation 
resulting in pHF78 and pHF79, respectively. 
presence of antibiotics and 0.05% arabinose, until they reached mid-exponential phase 
(OD610=0.35-0.4). The p-galactosidase activity of these transformants was quantified in 
an ONPG assay ( described above) as a measure of nuo promoter activity (17, 102). 
Computer Analysis 
Protein sequence analysis was performed using the BestFit, Gap, Publish, and 
PeptideSort programs within the Wisconsin Package software (version 8.1) of the Genetic 
Computer Group ( 42). Protein sequence motifs were identified by searching the PROS/TE 
Dictionary of Protein Sites and Patterns, also part of the Wisconsin Package. Autoradiographs 
of the RNA dot blots, northern blots, and the photograph of the RNA agarose gel were scanned 
using DeskScan II (56) and the images were compiled in PowerPoint (77). 
CHAPTERIII 
EXPERIMENT AL RESULTS 
Polarity of nuo Mutants 
To determine whether each nuo mutation exerts a polar effect upon transcription 
of downstream genes, we performed RNA dot blot analysis. Additionally, this technique 
allowed us to confirm the construction of each mutation beyond the restriction analysis, 
Southern blotting, and/or PCR that had been used to first identify each mutation. From 
cells carrying either the wild-type nuo locus (strains CP875 and CP366) or the mutant 
alleles nuoB::Km (AJW844), nuoB-C::Cm (AJW853), nuoF::miniTnJOCm (AJW851), 
A(nuoF-L)-1 (CP938), nuoG::TnJ0-1 (CP910), AnuoGJ (AJW931 and AJW1516), 
nuoG2 (AJW1470 and AJW1517), nuoH::Km (AJW845), nuol::Km (AJW846), 
nuoM::miniTnlOCm (AJW852), or nuoN::Km (AJW847), we purified total cellular RNA, 
transferred that RNA directly to multiple nitrocellulose membranes, and then hybridized 
each membrane with one of ten nuo probes (Fig. 9). Each probe hybridized to RNA 
extracted from wild-type cells (lanes 1 and 2). Similarly, all probes complementary to 
sequences located upstream of the reported location of each insertion hybridized to RNA 
extracted from mutant cells. In contrast, probes complementary to sequences 
downstream of each insertion hybridized poorly, if at all. For example, the upstream 
probes nuoA, nuoB, nuo 'CDE ', nuoD, and nuoF, but not the downstream probes CTR, 
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Fig. 9. Autoradiograph of RNA dot blots. Total RNA was purified from wild-type or 
nuo mutant cells, 0.5 µg transferred directly to multiple nitrocellulose membranes, and 
probed with the nuo genes or fragments indicated on the left. Lanes: 1, wild-type (strain 
CP875); 2, wild-type (CP366); 3, nuoB::Km (AJW844); 4, nuoB-C::Cm (AJW853); 5, 
nuoF::miniTnlOCm (AJW851); 6, il(nuoF-L)-1 (CP938); 7, nuoG::Tnl0-1 (CP910); 8, 
ilnuoGJ (AJW931); 9, nuoH::Km (AJW845); 10, nuol::Km (AJW846); 11, nuoN::Km 
(AJW847). The hybridization pattern for the nuoM::miniTnlOCm strain (AJW852) was 
identical to that for the nuoN::Km strain (AJW847; lane 11); the hybridization pattern 
for the ilnuoG 1 strain AJWl 516 was identical to that of AJW93 l (lane 8). Every probe 
hybridized to RNA from both nuoG2 strains, AJW1470 and AJW1517 (data not shown). 
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nuoH, nuol and nuo 'MN3 ', hybridized with RNA from the nuoG: :Tnl 0- l strain (lane 7). 
The faint signal observed with the nuoG probe likely resulted from its hybridization ·with 
RNA encoded by the portion of nuoG located upstream of the insertion. We observed 
similar hybridization patterns with RNA extracted from every nuo mutant constructed by 
insertion (lanes 4, 5, 9, 10, and 11), with one exception: RNA from the nuoB::Km mutant 
(lane 3) hybridized with the downstream probe nuo 'CDE'. The location of the 
nuoB::Km mutation (strain AJW844) relative to that of mutations nuoB-C::Cm and 
nuoF::miniTnlOCm was verified genetically (97.4% and 70.8% co-transformation 
frequency, respectively) and confirmed by Southern blot analysis (data not shown). 
Based on these two results, we conclude that the insertion does reside within the nuoB 
open reading frame. The signal we observed with nuoB: :Km RNA when probed with the 
nuo 'CDE' probe is not likely due to non-specific hybridization with any portion of nuoA 
or nuoB; if that were the case, we would have expected a signal with every RNA. 
Instead, it is possible that the signal is a result of contamination of the RNA. In contrast 
to nuo mutants carrying insertions, those harboring the deletion alleles ll.(nuoF-L)-l (lane 
6) or ll.nuoGJ (AJW931, lane 8) or those carrying the tandem duplication nuoG2 
(AJW1470 and AJW1517, data not shown) exhibited different patterns. With these three 
mutations, probes complementary to sequences both upstream and downstream of the 
respective mutations hybridized. The CTR, nuoG, nuoH, and nuol probes did not 
hybridize with RNA isolated from the ll.(nuoF-L)-l strain (lane 6), presumably because 
those genes had been deleted from the chromosome. Likewise, the CTR probe did not 
hybridize with RNA isolated from the ll.nuoGJ strain (AJW931, lane 8). 
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On the basis of these observations, we conclude that each insertion used to 
construct a nuo mutant exerted a polar effect upon downstream transcription. In contrast, 
the two deletions and the tandem duplication each exerted no polar effect. Moreover, the 
!1nuoGJ and nuoG2 alleles represent the only non-polar mutations constructed within a 
single nuo gene. 
Northern blot analysis 
In an effort to examine individual nuo transcripts, we performed northern blot 
analysis on total RNA isolated from either wild-type or !1(nuoF-L )-1 mutant cells. We 
chose to examine the transcription of two genes, nuoA and nuoH. We anticipated that if 
there were a single nuo transcript, then both probes would identify that transcript. 
Likewise, if there were multiple nuo transcripts, then we may be able to identify some aor 
all of them using these two probes. Additionally, by comparing the hybridization patterns 
obtained with the nuoA probe versus the nuoH probe, we could determine whether the 
signal we observed was specific or non-specific hybridization. Finally, we used the 
unrelated acsA probe to serve as a positive hybridization control. 
RNA was extracted from wild-type cells (CP875) at OD610=0.25, 0.50, and 0. 75 
and from !1(nuoF-L)-1 mutants cells (CP938) at OD610=0.50. A photograph of the RNA 
agarose gel following electrophoresis is shown in Fig. 10. Both the 16S and 23S rRNA 
bands are clearly visible for each sample. The RNA was transferred to a nitrocellulose 
membrane overnight by capillary action then heat- and UV-fixed to the membrane. The 
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Fig. 10. RNA agarose gel. Cells were grown in TB at 32°C to the indicated optical 
density at which point total RNA was extracted as described in Materials and 
Experimental Methods. 5 µg of total RNA from wild-type cells (CP875) and A(nuoF-L)-
1 mutant cells (CP938) was denatured at 65 °C for 15 min in the presence of2M 
formaldehyde, 50% formaldehyde, and lX MOPS then electrophoresed on a 1 % agarose 
gel containing 2M formaldehyde and 50% formamide in lX MOPS running buffer. 3 µl 
of 1 mg/ml EtBr was added directly to each RNA sample prior to electrophoresis. The 
RNA marker sizes are indicated on the left (Gibco-BRL). The 23S (3.7-kb) and 16S 
(1.7-kb) rRNA bands are indicated on the right. Not shown: A nuoA DNA fragment and 
a nuoH DNA fragment were run on the gel to serve as positive hybridization controls 
during northern blot analysis. 
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membrane was probed with a nuoA probe, stripped, probed with a nuoH probe, stripped, 
and probed with an acsA probe. 
The nuoA probe hybridized in a diffuse pattern with RNA from both wild-type 
and a(nuoF-L)-1 mutant cells (Fig. 1 lA). The signal appeared to center on the rRNA 
bands and no signal was observed that exhibited slower mobility than the 23S rRNA 
band. The nuoH probe also hybridized in a diffuse pattern centered around the rRNA 
bands (Fig. 1 lB), but it did not hybridize to RNA extracted from the a(nuoF-L)-1 
mutant. This is expected since the nuoH gene is deleted from the chromosome in this 
mutant. The lack of a nuoHhybridization signal in the a(nuoF-L)-1 mutant indicates a 
lack of non-specific hybridization with wild-type RNA. We observed that the 
hybridization signal from RNA extracted from wild-type cells at OD610 =0.75 was less 
intense than the signals from RNA extracted at OD610 =0.25 or 0.5. Without an additional 
loading control, we can not draw any conclusions about whether the difference in signal 
intensities is significant. 
To verify the integrity of total RNA, we probed the blot with an internal fragment 
of the acsA gene that corresponded approximately in size to the nuoA probe (Fig. 1 lC). 
A single transcript of about 2.1-kb was observed. This result had been obtained 
previously (Kumari and Wolfe, manuscript in preparation). Furthermore, when we used 
nuoA to probe a different blot ( one that previously had displayed the acsA transcript; a 
gift from S. Kumari), we again observed the diffuse hybridization pattern observed with 
the first blot (Fig. 1 lD). 
A 
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B wild-type ll(nuoF-L) 
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nuoA 
D wild-type acsA::Km 
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Fig. 11. Autoradiographs of northern blots. RNA was transferred electrophoretically 
from the agarose gel (Fig. 10) to a nitrocellulose membrane. The membranes were 
stripped between each probing. Probes are indicated in the gray boxes. (A) nuoA 
probed membrane, (B) nuoH probed membrane, (C) acsA probed membrane. The blots 
in A-C were exposed to film for 8 days. (D) nuoA probed membrane; a different 
membrane was used, one that had been probed previously with acsA and stripped. The 
blot was exposed for 5 days. Wild-type, strain CP875; f:t.(nuoF-L) -1, CP938. 
dacsA::Km mutant, AJW803. 0D610, the point at which the RNA was extracted from 
the respective cells. The 23S and 16S rRNA bands are indicated to the right of each 
blot. 
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These results suggest that i) the hybridization signals we observed are specific for 
nuo, ii) the hybridization pattern we observe with the nuoA and nuoH probes is a 
phenomenon associated with nuo and is not due to non-specific hybridization, but iii) the 
nuo transcript(s) does not appear to be stable under the conditions tested. 
Phenotypes of nuo Mutants 
To test whether i) the newly constructed llnuoGJ and nuoG2 mutants exhibited 
the previously described Nuo- phenotypes and ii) all of the isogenic nuo mutants 
exhibited the same phenotypes, we characterized the mutants by subjecting them to a 
series of tests, each shown previously to distinguish wild-type cells from those of nuo 
mutants (4, 8, 23, 24, 67, 68, 91). On the basis of the five phenotypic analyses, we 
conclude that all of the nuo mutants tested exhibit a pleiotropic Nuo- phenotype. 
Additionally, the data suggests that the nuoN mutant possesses a subassembled, 
cytoplasmic peripheral fragment (NDF). 
First, we inoculated cells carrying either the wild-type nuo locus (strain CP366) or 
the mutant alleles nuoG::Tnl0-1 (CP932) or llnuoGJ (AJW931), at the center of TB 
swarm plates, incubated those plates at 32°C until the outer, serine ring had reached the 
edge, and examined them for the presence or absence of the inner, aspartate ring. Wild-
type cells formed both rings (Fig. 12A). In contrast, the nuoG::TnJ0-1 mutant 
wild-type 
&iuoGJ 
nuoG::TnlO 
&iuoGJ 
integrant 
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Fig. 12. Photographs of the swarms produced by the (A) wild-type strain (CP366), (B) 
nuoG::TnlO-l mutant (CP932), (C) AnuoGJ mutant (AJW931), and (D) the AnuoGJ 
integrant (AJW932), Cells were inoculated at the center of a TB swarm plate 
containing 0.25% agar, and the plates incubated at 32 °C until the outer, serine ring 
reached the edge of the swarm plate. 
(Fig. 12B), the AnuoGJ mutant (Fig. 12C), and all other nuo mutants failed to form the 
inner ring (Table 4). 
Second, we inoculated TB with wild-type cells (strain CP875) or those that carry 
the mutant alleles A(nuoF-L)-l (CP938), nuoG::TnlO-l (CP910), AnuoGJ (AJW1516), 
or nuoG2 (AJW1517), aerated the cultures at 32°C, and monitored their growth as a 
function of optical density (Fig. 13). Prior to mid-exponential phase, both wild-type and 
mutant cells grew at similar rates. Whereas wild-type cells continued relatively rapid 
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Fig. 13. Tryptone broth growth curve. Cells were grown in TB at 32°C. Growth was 
monitored as a function of optical density versus time. The OD610 of the wild-type strain 
CP875 (■), the .d(nuoF-L)-1 strain CP938 (.d), the nuoG::Tnl0-1 strain CP910 (0), the 
.dnuoGJ strain AJW1516 (v), and the nuoG2 strain AJW1517 (◊). The mean of six 
independent experiments is plotted for each strain. The error bars represent ±SEM. 
growth beyond OD610=0.3, mutant cells abruptly reduced their growth rate. Regardless of 
genetic background, all other nuo mutants exhibited similar behavior (Table 4). 
Third, to examine the cells growth on acetate as the sole carbon source, we 
inoculated M63 minimal plates supplemented with 25 mM acetate or 0.25% glucose with 
wild-type cells (strain CP875) and those carrying the mutant alleles nuoG::Tnl0-1 
(CP910), .dnuoGJ (AJW1516), or nuoG2 (AJW1517), incubated those plates at 32°C for 
55.5 h before photographing them. Relative to wild-type cells, mutant cells formed very 
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small colonies on M63 acetate plates (~0.5 mm compared to ~ 1.0 mm for wild-type cells) 
(Fig. 14). In contrast, all cells formed equally-sized colonies (~1.0 mm) on M63 glucose 
wild-type nuoG::TnlO 
!1nuoGJ nuoG2 
Fig. 14. Growth on acetate. Photographs of colonies produced by the wild-type strain 
CP875, the nuoG::Tnl0-1 strain CP910, the !:,,.nuoGJ strain AJW1516, and the nuoG2 
strain AJW1517. Cells were inoculated on minimal media (M63) plates supplemented 
with 25 mM sodium acetate (pH 7.0) and the plates were incubated at 32°C for 55.5 h. 
plates. All other nuo mutants tested formed equivalent colony sizes (Table 4). 
Fourth, complex I activity was examined in selected mutants by measuring the 
NADH ferricyanide (FeCN) and d-NADH FeCN activities in their membrane fractions. 
These experiments were performed by Thorsten Friedrich and colleagues at the Heinrich-
Heine-Universitat Diisseldorf. Whereas membrane fractions from wild-type cells 
exhibited both these complex I activities, membrane fractions of the mutant cells 
exhibited much lower levels of these activities (10) (Table 4). The activities were not 
completely abolished in the nuo mutants presumably because the second NADH 
dehydrogenase, NDH-11, also reacts with both substrates (37). 
56 
Finally, using electron-paramagnetic resonance spectroscopy (EPR) analysis that 
detects Fe-S centers of complex I in the membrane fraction of wild-type cells (67, 68, 
114), Friedrich et al. tested for the presence of subcomplexes of complex I in the mutants. 
The analysis revealed no detectable amounts of complex I or subcomplexes of complex I 
in the membrane fractions or cytoplasm of any of the mutants tested with one notable 
exception: EPR analysis detected Fe-S centers in the cytoplasm of the nuoN mutant, but 
not in its membrane fraction (10) (Table 4). The presence ofFe-S centers in the 
cytoplasm of nuoN mutants was confirmed by the purification of the peripheral fragment 
(NDF) from those cells which was subsequently shown to resemble the NDF of purified 
complex I in both enzyme activity and EPR spectroscopy (10). 
Complementation of the ll.nuoGl and nuoG2 Alleles 
We tested for complementation in cis (32) with multiple, independent isolates of 
strains that carry both the wild-type nuoG and the mutant ll.nuoGJ alleles (strains 
AJW932 and AJW1459) or that carry both the wild-type nuoG and the mutant nuoG2 
alleles (AJWl 4 72) on their chromosomes by scoring each strain for their ability to 
produce the inner ring in swarm assays (Fig. 12D; Table 4). Multiple, independent 
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TABLE 4. Summary of Nuo Phenotypes 
Growth NADH/ TB on dNADH EPR Strain nuo swarm growth M63+ spectroscopy 
mutation plate3 FeCN 
curveb 25mM 
activityd analysise 
acetatec 
CP875 w.t. + + + + + 
CP366 w.t. + + NDr,g + + 
AJW844 nuoB::K.m -h -h 
AJW853 nuoB-C::Cm NDr NDr 
AJW851 nuoF: :miniTnl OCm -h NDr 
CP938 !l(nuoF-L)-l 
CP910 nuoG::TnlO-l 
CP932 nuoG::TnlO-l NDr,g NDr NDr 
AJW931 !lnuoGJ NDr,g 
AJW1516 !lnuoGJ NDr NDr 
AJW1470 nuoG2 NDr,g NDr NDr 
AJW1517 nuoG2 NDr NDr 
AJW845 nuoH::K.m -h -h 
AJW846 nuol::K.m -h -h 
AJW852 nuoM::miniTnl OCm NDr NDr 
AJW847 nuoN::K.m -h +h 
AJW932 CP366pHF17 + + NDr,g NDr NDr 
integrant 
AJW1459 AJW931 + + NDr,g NDr NDr 
pAJWl 05!1Pstl 
integrant 
AJW1472 AJW1470 + + NDr,g NDr NDr 
pAJWl05A.Pstl 
integrant 
AJW1567 !lnuoGJ NDr NDr 
nuoM: :miniTnl OCm 
AJW1568 !lnuoGJ nuoN::K.m NDr NDr 
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Growth NADH/ TB on EPR 
Strain nuo 
mutation 
swarm growth plate• 
dNADH M63+ spectroscopy FeCN 
curveb 25mM 
activityd analysise 
acetatec 
AJW1569 nuoG2 
nuoM: :miniTnJ OCm 
AJW1580 nuoB::Km 
nuoF: :miniTnJ OCm 
AJW1581 nuoB::Km 
nuoB-C::Cm 
AJW1582 t!nuoGJ nuoH::Km 
AJW1583 t!nuoG 1 nuol: :Km 
AJW1584 nuoG2 nuoH::Km 
a +, the presence of an inner, aspartate ring ; -, the absence of the inner ring. 
b +, no growth defect;-, growth defect. 
c +, good growth(~ 1.0 mm colonies);-, poor growth (5:0.5 mm colonies). 
NDr 
NDr 
NDr 
NDr 
NDr 
NDr 
d +, presence of the activities in membrane fractions;-, decrease in these activities. 
e +, the presence ofFe-S centers characteristic of complex I;-, lack of detectable Fe-S centers. 
rND, not done for this study. 
8 Strain background was Ace- prior to introduction of nuo mutation(s). 
h Mutation analyzed in a different, but related, background. 
NDr 
NDr 
NDr 
NDr 
NDr 
NDr 
isolates of each strain formed an inner, aspartate ring despite the fact that vector sequence 
interrupts the partially duplicated nuo locus in these strains (see Fig. 5). Additionally, 
strains AJW932, AJW1459, and AJW1472 did not exhibit the TB growth defect (Table 
4). Since these strains exhibited these two Nuo+ phenotypes, we conclude that the 
!::..nuoGJ and nuoG2 alleles can be complemented and that the mutant alleles are 
recessive. 
Translational Analysis 
We examined the ability of wild-type and nuo mutant cells to synthesize the 
NuoCD and NuoG subunits (67), using a polyclonal antibody directed against purified 
complex I (#2409). The NuoCD subunit has been identified as a single polypeptide (a 
fusion protein) in E. coli ( 41 ). This finding is consistent with a study of the bacterium 
Buchnera aphidicola which described a protein homologous to NuoC at its N-terminus 
yet homologous to NuoD at its C-terminus (20). However, due to a sequence 
discrepancy, it is not yet clear the mechanism for such a fusion protein. There is 
possibility that the proposed nuoC stop TGA codon may code for the amino acid 
selenocysteine or that the stop codon is simply out of frame and therefore only a single 
nuoCD open reading frame exists. 
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We identified the bands that correspond to NuoCD and NuoG by comparing the 
pattern of bands from purified complex I (67) (Fig. 15A and B, lane 1) to those of a 
mixture of purified complex I and whole cell lysate from wild-type cells (strain CP366) 
(Fig. 15A and B, lane 2) to whole cell lysates from wild-type cells alone, strains CP366 
(Fig. 15A and B, lane 3) and CP875 (Fig. 15A only, lane 4). We examined both wild-
type strains because the mutants were constructed in the two backgrounds. We failed to 
detect NuoCD only in strains that carry an insertion mutation upstream of nuoC (Fig. 15A 
only, lanes 5 and 6), but detected NuoCD in all other strains (Fig. 15A, lanes 3, 4, and 7-
14; Fig. 15B, lanes 3-9). Similarly, we failed to detect NuoG in strains that either lack 
nuoG or harbor an insertion mutation upstream of or within nuoG (Fig. 15A, lanes 5-9; 
Fig. 15B, lanes 4 and 5), but detected NuoG in all other strains (Fig. 15A, lanes 3, 4, 
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Fig. 15. Immunoblot analysis using E. coli anti-complex I polyclonal antibody 
following SDS-PAGE (7.5% polyacrylamide) and transfer to nitrocellulose. 
Molecular weight markers are indicated on the right; the NuoG and NuoCD subunits are 
identified on the left. (A) Analysis ofwhole-cell lysates prepared from wild-type or nuo 
polar mutant cells. Lanes: 1, purified complex I; 2, purified complex I mixed with wild-
type lysate (strain CP366); 3, wild-type (CP875); 4, wild-type (CP366); 5, nuoB::Km 
(AJW844); 6, nuoB-C::Cm (AJW853); 7, nuoF::miniTnlOCm (AJW851); 8, ll(nuoF-L)-
1 (CP938); 9, nuoG::Tnl0-1 (CP910); 10, nuoH::Km (AJW845); 11, nuo/::Km 
(AJW846); 12, nuoM::miniTnlOCm (AJW852); 13, nuoN::Km (AJW847). Cells were 
grown with aeration in TB at 32 °C until cultures reached mid-exponential phase 
(OD610=0.35-0.4). 100 µg whole-cell lysate loaded in each lane. (B) Analysis ofwhole-
cell lysates prepared from wild-type or nuoG mutant cells. Lanes: 1, purified complex I; 
2, purified complex I mixed with wild-type whole-cell lysate (CP366); 3, wild-type 
(CP366 ); 4, ll(nuoF-L)-1 (CP938); 5, nuoG::Tnl0-1 (CP910); 6, llnuoGJ (AJW931); 7, 
nuoG2 (AJW1470). Cells were grown as in Panel A. 100 µg whole cell lysate loaded in 
each lane. 
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11-14; Fig. 15B, lane 3). Cells that carry the alleles llnuoGJ (AJW931 (Fig. 15B, lane 6) 
and AJW1516 (data not shown)) or nuoG2 (AJW1470 (Fig. 15B, lane 7) and AJW1 517 
(data not shown)) synthesized proteins that exhibited faster and slower mobility, 
length Predicted 
nuoG allele (aa's) ft4 (kDa) 
wild-type 909 100.3 
~uoGl 838 93.2 
nuoG2 939 103.5 
NuoG subunit (N ➔ C-terminus) 
I 
I 
Fig. 16. Putative NuoG peptides. Length and molecular mass (Mr) of translation 
products from the wild-type and mutant nuoG alleles as predicted by PeptideSort (41). 
The C-terminal region (CTR) of NuoG (gray-hatched). The deletion in llnuoG 1 shifts the 
remainder of the altered NuoG C-terminus out-of-frame (dark gray). The duplication in 
nuoG2 shifts the duplicated CTR (black-hatched) and the remainder of the altered NuoG 
C-terminus (dark gray) out-of-frame. 
respectively, compared to the wild-type NuoG. The apparent molecular mass of each 
variant roughly corresponded to the predicted product of their respective alleles ( 42) (Fig. 
16). In addition, the steady state level of the smaller variant produced by llnuoG 1 cells 
(Fig. 15B, lane 6) seemed to be significantly less than that of the full-length NuoG 
protein produced by the wild-type strain CP366 (Fig. 15B, lane 3). In contrast, the 
amount of NuoCD protein produced by both strains seemed to be roughly equivalent. On 
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the basis of these observations, we conclude that the llnuoGJ and nuoG2 alleles result in 
the synthesis of altered forms of the NuoG subunit. The NuoG subunit is subject to 
proteolytic digestion in disrupted cells (33). Perhaps the truncated NuoG subunit 
resulting from the llnuoG 1 allele is less abundant as a result of even more rapid 
proteolytic digestion. 
Effect of nuo Mutations on nuo Promoter Activity 
To examine the effect that nuo mutations exert upon nuo promoter activity, we 
monitored p-galactosidase activity from a nuoPA '::lacZYA operon fusion. We 
transformed cells carrying the wild-type nuo locus (strain CP875) or the mutant alleles 
nuoB::Km (AJW844), ll(nuoF-L)-l (CP938), nuoG::TnlO-l (CP910), llnuoGJ 
(AJW1516), nuoG2 (AJW1517), nuoH::Km (AJW845), nuol::Km (AJW846), nuoM::Km 
(AJW852), nuoN::Km (AJW847), llnuoGJ nuoH::Km (AJW1582), llnuoGJ nuol::Km 
(AJW1583), nuoG2 nuoH::Km (AJW1584), llnuoGJ nuoM::Cm (AJW1567), llnuoGJ 
nuoN::Km (AJW1568), or nuoG2 nuoM::Cm (AJW1569) with pHF9, a multi-copy 
plasmid that carries the nuoP A ': :lacZYA operon fusion (Fig. 17 A) or with its parental 
vector, pRS415. We grew the resultant transformants in TB at 32°C, harvested and lysed 
them as the cultures reached mid-exponential phase (0D610=0.35-0.4), and measured their 
p-galactosidase activity. The mean sp act±SEM of at least six independent experiments 
was plotted (Fig. 17B). Wild-type cells transformed with the vector control pRS415 
displayed little or no p-galactosidase activity (sp act of 0.02±0.01). Relative to pHF9 
transformants of wild-type cells, those of the nonpolar mutants llnuoGJ and nuoG2 
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exhibited reduced P-galactosidase activity (sp act of 10.3±0.76 vs. 4.83±1.06 and 
1.04±0.06, respectively). In contrast, pHF9 transformants of the llnuoGJ nuoH::Km, 
llnuoGJ nuol::Km, and nuoG2 nuoH::Km double mutant strains exhibited significantly 
higher activities (sp act of 27.50±5.60, 27.11±2.55, and 30.00±1.49, respectively) than 
did the respective llnuoGJ, nuoG2, or wild-type transformants. This increase in activity 
cannot be due merely to the presence of the nuoH: :Km or nuol: :Km mutations only since 
transformants of those single mutants exhibited activities similar to that of the wild-type 
transformants (10.20±0.68 and 15.74±1.47, respectively). In fact, transformants of all the 
single mutants tested (except for the llnuoGJ and nuoG2 mutants) displayed activities 
similar to that of the wild-type transformants. The double mutants llnuoGJ nuoM::Cm, 
llnuoGJ nuoN::Km, and nuoG2 nuoM::Cm transformed with pHF9 displayed activities 
only slightly higher than wild-type transformants (16.40±1.56, 18.96±2.04, and 
13.52±0.582, respectively). We do not know why there was a difference in the level of 
activity between the llnuoGJ and nuoG2 transformants, importantly their activity is 
lower than that for wild-type transformants. Moreover, an additional mutation 
downstream of either the llnuoG 1 or nuoG2 mutation eliminated any significance 
difference in those transformants' activities. On the basis of these data, we propose that 
NuoG participates in the regulation of nuo transcription possibly in conjunction with 
some other Nuo subunit(s). 
Interestingly, nuoG::TnlO transformant exhibited levels of P-galactosidase 
activity similar to the wild-type transformant whereas the llnuoGJ and nuoG2 
transformants displayed lower levels. This difference between the nuoG mutants may be 
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Fig. 17. Effect of nuo mutations on nuo promoter activity. (A) pHF9, a multi-copy 
nuoPA '::lacZYA transcriptional (operon) reporter fusion. Designations as in Fig. 6 
legend. (B) p-galactosidase activity assay. Cells were grown in TB at 32 °C to mid-
exponential phase (OD610=0.35-0.4), harvested, lysed by sonication, and centrifuged to 
separate the cytoplasmic from the membrane fraction. The p-galactosidase activity of the 
cytoplasmic fractions was quantified as U/mg protein where U= µmol ONP formed/min. 
The figure is a representation of at least six independent experiments. wt (CP875); 
nuoB::Km (AJW844); a(nuoF-L)-1 (CP938); nuoG::Tnl0-1 (CP910); nuoH::Km 
(AJW845); nuol::Km (AJW846); nuoM::miniTnJOCm (AJW852); nuoN::Km (AJW847); 
anuoGJ (AJW1516); nuoG2 (AJW1517); anuoGJ nuoH::Km (AJW1582); anuoGJ 
nuol::Km (AJW1583); nuoG2 nuoH::Km (AJW1583); anuoGJ nuoM::Cm (AJW1567); 
anuoGJ nuoN::Km (AJW1568); nuoG2 nuoM::Cm (AJW1569). 
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attributed to the polarity of the mutations. In the nuoG::TnlO mutant, we saw that all 
transcription downstream of the mutation is eliminated therefore, none of the genes 
nuoG-N are expressed. However, transcription of downstream genes does not seem to be 
affected in either the dnuoGJ or nuoG2 mutant. It is likely that the decrease in P-
galactosidase activity in the dnuoGJ and nuoG2 transformants is due not to the presence 
of the altered NuoG subunits, rather it is due to the presence of the downstream Nuo 
subunits unable to properly assemble. 
Effect of Overexpression of nuo Genes on nuo Promoter Activity 
We observed a significant decrease in expression from the nuo promoter only in 
the dnuoGJ and nuoG2 mutants transformed with pHF9 and observed a decrease in 
expression when transcription of nuoH-N was abolished by an additional mutation in 
either nuoH or nuol. From our dot blot analysis, we know that the dnuoGJ and nuoG2 
mutants transcribe nuoH-N. We assume that the NuoH-N subunits are synthesized in 
these strains. On the basis of these results, we propose that NuoH-N may affect nuo 
expression by repressing promoter activity. We tested whether the overexpression of 
nuoH-N could decrease expression from the nuo promoter. We transformed wild-type 
(CP875) cells with pHF9 (Fig. 6) alone or in conjunction with the compatible vector 
pBAD33 or with constructs derived from pBAD33 that contain the nuoH-N genes either 
in the same orientation as the P8AD promoter, pHF78, or in the opposite orientation from 
the P8AD promoter, pHF79 (Fig. 8). We plated these transformants on LB X-gal indicator 
plates containing the appropriate antibiotic(s) and 0.05% arabinose (for P8 AD induction). 
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These plates were incubated at 32 °C ON at which time the colonies were examined for 
their color. Blue color signified P-galactosidase activity expressed from pHF9, whereas 
white color indicated a little or no P-galactosidase activity (78). We quantified the P-
galactosidase activity by performing an ONPG assay ( described in Materials and 
Experimental Methods) with transformants grown in TB at 32°C to mid-exponential 
phase (OD610=0.35-0.4). The results of these experiments are presented in a table below. 
TABLE 5. Effect of nuoH-N overexpression on nuo promoter activity 
P-galactosidase 
activity 
Color on X-gal: 
sp act (U/mg): 
Wild-type (CP875) cells transformed with: 
nuoPA '::lacZYA 
blue 
~10.0 
nuoPA '::lacZYA + 
vector 
blue 
ND 
nuoPA '::lacZYA + nuoPA '::lacZYA + 
nuoH-N 
white 
<0.001 
nuoN-H 
white 
<0.001 
Based on the results we observed on the indicator plates, we conclude that the P-
galactosidase activity is decreased in cells transformed with constructs carrying the 
nuoH-N genes in either orientation (pHF78 or pHF79). This decrease is not merely due 
to the presence of the pBAD33 vector-backbone, since no decrease was observed in cells 
transformed with the vector pBAD33 without any nuo insert. The results of the ONPG 
assay demonstrate that the decrease in P-galactosidase activity is significant. The nuoH-
N genes are oriented opposite that of the P8 AD promoter in pHF79; their expression may 
be driven by the araC gene, the cat gene, or perhaps by some internal nuo promoter. 
Evidence for an internal promoter between nuoG and nuoN in S. typhimurium has been 
presented by Archer and Elliott (3). 
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These results, while inconclusive, are intriguing. We would need to determine 
whether nuoH-N are in fact being expressed in each construct before concluding that it is 
the overexpression of nuoH-N leads to the decrease in nuo promoter activity we observed. 
Studies with nuo: :lacZ Protein Reporter Fusions 
To examine whether NuoA affects the expression from the nuo promoter, we 
constructed two nuo::lacZYA protein fusions, one that contained all of nuoA and one that 
did not. These fusions, pHF13 (the short fusion) and pHF14 (the long fusion), are 
depicted in Fig. 18A. pHF13 is analogous to the operon fusion, pHF9: it contains nuoP 
and the proximal third of nuoA cloned into the protein fusion vector pRS414. pHF 14 
contains a slightly larger insert: it includes nuoP, all of nuoA, and the proximal third of 
nuoB cloned into pRS414. The main difference between the two protein fusions is the 
presence of only a partial nuoA gene in pHF13 or the entire nuoA gene in pHF14. We 
assume that NuoA is synthesized from pHF 14, but not from pHF 13, and therefore the 
levels ofNuoA would be higher in cells transformed with pHF14 than in those 
transformed with pHF13. We transformed wild-type cells (CP875) with each of the 
protein fusions or their parental vector, pRS414. We grew the cells in TB at 37°C and 
measured their P-galactosidase activity over a growth curve (Fig. 18B). Cells 
transformed with pHF 13 display a higher level of p-galactosidase activity throughout the 
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Fig. 18. Expression studies with protein fusions. (A) pHF13 and pHF14, multi-copy 
nuo::lacZYA translational (protein) reporter fusions. pHF13 contains a 443-bp nuo insert 
whereas pHF14 contains a 992-bp nuo insert. Designations as in Fig. 7. (B) P-
galactosidase activity assay. Wild-type (CP875) cells transformed with vector pRS414 
(■), pHF13 (e), or pHF14 (•). Transformants were grown in TB at 32°C and samples 
removed at the indicated time points. The cells were lysed by sonication and centrifuged 
to separate the cytoplasmic from the membrane fraction. The P-galactosidase activity of 
the cytoplasmic fractions was quantified as U/mg protein where U= µmol ONP 
formed/min. The mean±SEM of six independent experiments is plotted. 
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growth curve than do cells transformed with pHF14. These results suggest that the 
overexpression of nuoA reduces expression from the nuo promoter. This data also 
substantiates a role for Nuo subunits, in this case NuoA, in the regulation of nuo 
expression. 
The Impact of Sigma Factors on nuo Promoter Activity 
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Three reports by different research groups describe or make reference to the 
presence of 0 70-dependent promoter elements, specifically the -10 and/or -35 sequences, 
within the nuo promoter in both E.coli and S. typhimurium (3, 12, 114). We tested the 
hypothesis that the nuo promoter is, in fact, 0 70-dependent. We used the nuoPA '::lacZYA 
operon fusion, pHF9 (Fig. 6 and 17A), to study the effect of the sigma factors 0 70 (the 
"housekeeping" sigma factor), as ( 0 38; the stationary phase/oxidative stress sigma factor), 
and 0 54 ( oN; nitrogen/formate metabolism sigma factor) on nuo promoter activity (Fig. 
19). 
We transformed the operon fusion, pHF9, into wild-type cells (Strain CP875) or 
sigma factor mutants (rpoDTs, strain UQ285; rpoS::Km, AJW1015; or rpoN::Tnl0-1, 
AJW1409) and grew the transformants in TB supplemented with the requisite antibiotics 
at the temperatures indicated. We harvested the cells at the indicated times and 
measured their p-galactosidase activity as described previously. 
To determine whether the nuo promoter is 0 70-dependent as had been reported 
previously, we examined nuo expression in an RpoDTs strain. We measured the P-
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galactosidase activity of rpoD(Ts) cells (strain AJW1337) transformed with pHF9. 
Surprisingly, we observed only a slight decrease in the P-galactosidase activity exhibited 
by transformants at the permissive temperature (33 °C; RpoD+) versus those at the 
restrictive temperature (44 °C; RpoD-) (Fig. 19A). 
To determine whether the nuo promoter is 0 8-dependent, we measured the P-
galactosidase activity of wild-type cells (CP875) and rpoS::Km cells (AJW1015) 
transformed with pHF9. We observed only a slight decrease in P-galactosidase activity in 
Rpos- transformants (AJW1015 pHF9) compared to Rpos+ transformants (CP875 pHF9; 
Fig. 19B). A similar result was achieved in S. typhimurium, where a katF (rpoS) 
mutation introduced into a strain harboring a single-copy nuo promoter fusion resulted in 
a slight decrease in P-galactosidase activity (3). 
To determine whether the nuo promoter is 0 54-dependent, we measured the P-
galactosidase activity of wild-type cells (CP875) and rpoN::Tnl0-1 cells (AJW1409) 
transformed with pHF9. RpoN- transformants displayed a significantly reduced level of 
p-galactosidase activity relative to the RpoN+ transformants (Fig. 19C). 
While these studies are not exhaustive, we conclude that i) 0 70 and 0 8 play a minor 
role, if any, in regulating the nuo promoter and ii) 0 54 contributes greatly, either directly 
or indirectly, to expression from the nuo promoter. 
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Fig. 19. nuo promoter activity in various sigma factor mutants. p-galactosidase 
activity assays performed on cells transformed with the multi-copy nuoPA '::lacZYA 
operon fusion, pHF9 (refer to Fig. 6 and 17 A). Transformants were grown in TB at 
37°C, unless otherwise stated, and samples removed at the indicated time points. The 
cells were lysed by sonication and centrifuged to separate the cytoplasmic from the 
membrane fraction. The p-galactosidase activity of the cytoplasmic fractions was 
quantified as U/mg protein, where U= µmol ONP formed/min. (A) rpoD(Ts) cells (strain 
AJW1337) transformed with pHF9. Cells were initially grown at 33 °C (permissive 
temperature), then the culture was split and one half was grown at 33 °C, the other at 
44 °C (restrictive temperature). The arrow indicates the time point at which the cultures 
were split. RpoD+ (33 °C; ■), RpoD- (44 °C; e). (B) RpoS+ (wild-type, CP875; ■) or 
Rpos- (rpoS::Km mutant, AJW1015; e) cells transformed with pHF9. (C) RpoN+ (wild-
type, CP875; ■) or RpoN- (rpoN::TnlO mutant, AJW1409; e) cells transformed with 
pHF9. 
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CHAPTERIV 
DISCUSSION 
Nuo Phenotypes 
We performed a genetic analysis of nuo, the E. coli locus that encodes the proton 
translocating NADH dehydrogenase, complex I. Examining physiological, biochemical, 
and molecular properties of mutants defective in nine of the fourteen nuo genes, we 
demonstrated that a mutation in any one of the nuo genes tested causes a complex I 
deficiency as measured by the inability of the mutant cells to i) form a inner, aspartate 
ring on chemotaxis swarm plates, ii) grow rapidly in TB beyond mid-exponential phase, 
iii) use acetate effectively as a sole carbon source, iv) exhibit membrane-associated 
(d)NADH-FeCN activity, and v) detect membrane-associated Fe-S centers. Since each 
nuo mutant exhibited all five Nuo- phenotypes, we used the swarm assay as a simple and 
reliable Nuo- screen. The mechanism for this phenotypic defect remains unclear. 
However, the absence of the inner, aspartate ring on swarm plates may result from the 
inability to respire aerobically: wild-type cells grown anaerobically in the presence or 
absence of an electron acceptor also do not form the inner ring (McNamara and Wolfe, 
unpublished observation). 
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Transcriptional Analysis 
All of the nuo insertion mutations tested (nuoB-C: :Cm, nuoF: :miniTnl OCm; 
nuoG::Tnl0-1, nuoH::Km, nuol::Km, nuoM::miniTnlOCm, and nuoN::Km) prevented 
transcription of downstream genes, as judged by RNA dot blot analyses, with the 
exception of the nuoB: :Km mutation. However, since we verified the location of the 
mutation genetically and the nuoB: :Km mutant cells did not seem to synthesize the 
NuoCD or NuoG subunit, as demonstrated by immunoblot analysis, the apparent 
incomplete polarity exhibited by this mutation may be artifactual. 
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l::,.nuoGJ and nuoG2 represent the first recessive, nonpolar mutations located 
within a single nuo gene. The RNA dot blot analyses revealed that both deletion 
mutations (l::,.(nuoF-L)-l and l::,.nuoGJ) and the duplication mutation (nuoG2) do not exert 
polar effects upon the transcription of downstream genes and complementation analyses 
demonstrated that both the l::,.nuoGJ and nuoG2 mutant alleles are recessive: strains that 
carry both the wild-type nuoG allele and either of these mutant alleles on their 
chromosomes formed inner rings on swarm plates and did not exhibit the TB growth 
defect. Since these integrant strains exhibited wild-type behaviors, we conclude that the 
two halves of the nuo locus can be expressed independently. Expression of the 
downstream half of the locus in these strains may result either from a promoter located 
within nuoG or the 3' end of nuoF or from a promoter located within the vector. 
Evidence for an internal promoter between nuoG and nuoN in S. typhimurium has been 
presented by Archer and Elliott (3). 
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We could not identify individual, discrete nuo transcripts using northern blot 
analysis. We believe that this lack of discrete transcript( s) did not occur because the total 
RNA was degraded during preparation or during transfer: both rRNA bands were intact 
and a discrete acsA transcript was identified. The signal we observed using the both nuo 
probes, however, not a result of non-specific hybridization: we observed a signal when 
RNA from !1(nuoF-L)-l cells was probed with nuoA DNA but not when probed with 
nuoHDNA. Unfortunately, the nuo transcript(s) does not appear to be stable under the 
conditions tested. Further analysis of nuo transcripts will require the use of alternative 
techniques such as primer extension, RNase protection, or in vitro transcription. 
Protein Analysis 
This is the first report of immunoblot analysis of E. coli cell lysates with an anti-
complex I antibody. By analyzing selected members of our mutant collection, we 
demonstrated that antibody #2409 recognizes both the NuoCD and NuoG subunits. As 
predicted, the !1nuoGJ and nuoG2 mutants synthesized smaller and larger variants of the 
NuoG subunit, respectively. Since all fourteen genes appear to be transcribed by !1nuoGJ 
and nuoG2 cells, these cells presumably synthesized wild-type versions of all the other 
Nuo subunits. Therefore, we conclude that functional complex I requires NuoG. 
Fe-S centers were detected in the cytoplasm of the nuoN mutant by EPR 
spectroscopy. The detection of these centers in the cytoplasm instead of associated with 
the membrane supports the hypothesis that NuoE, NuoF, and NuoG subunits can form the 
peripheral NDF in the absence of the membrane fragment. Furthermore, Braun and 
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colleagues (14) have recently shown that the NDF is properly assembled without the 
membrane fragment as long as the NuoCD subunit of the connecting fragment is present. 
We demonstrate here that the C-terminal defects caused by deletion or duplication of the 
235-bp CTR prevent complex I from functioning properly. Perhaps the altered NuoG 
subunits cannot properly incorporate into the NDF or, if incorporated, prevent the further 
assembly of other subunits. 
Expression Studies 
On the basis of the following evidence, we hypothesize that NuoG and at least one 
other downstream subunit affect nuo promoter activity. First, of all the mutants tested, 
only those carrying the l!!.nuoGJ or the nuoG2 mutation exhibited promoter activity 
markedly reduced from that exhibited by wild-type cells when transformed with the 
multi-copy nuoPA '::lacZYA operon fusion. This effect was not observed in nuoG::TnlO 
or nuoH: :Km transformants suggesting that it is not the lack a functional NuoG alone that 
causes an inhibitory effect at the nuo promoter. Second, this inhibitory effect was 
alleviated by the additional presence of the nuoH: :Km or nuol: :Km mutations. To a 
lesser extent, this was also true of the nuoM: :Cm or nuoN: :Km mutations. The nuoG 
double mutants that contain either the nuoH: :Km or nuol: :Km mutations exhibited a 
significant increase in promoter activity compared to those nuoG double mutants that 
contain either the nuoM: :Cm or nuoN: :Km mutations. This suggests that the repression 
observed in our experiments is orchestrated by a Nuo subunit(s) downstream ofNuoH, 
yet upstream of NuoM. 
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The overexpression of nuoH-N experiments are still incomplete. Since we 
observed the same effect on promoter activity in cells expressing nuoH-N in both 
orientations, we cannot conclude whether the effect is specifically due to the expression 
of those genes. First, the expression of nuoH-N from each construct would need to be 
verified by transcriptional and/or translational analysis. Second, if nuoH-N is being 
expressed, the origin of expression needs to be determined in the construct where the 
genes are oriented opposite that of the P8 AD promoter. Finally, the gene(s) responsible for 
the effect would need to be determined through deletion and mutational analysis. 
Our data also is consistent with the ability ofNuoA to exert influence on nuo 
promoter activity: cells that overexpress nuoA exhibited a reduced level of promoter 
activity relative to those that do not overexpress nuoA. Further support for this 
hypothesis comes from primer extension data from the S. typhimurium promoter (3, 29). 
E. coli cells transformed with a multi-copy plasmid containing both the S. typhimurium 
nuo promoter and nuoA exhibited the same levels of primer extension products as did 
those transformed with a control vector or untransformed S. typhimurium cells. These 
data are consistent with a role for NuoA as a repressor of nuo expression. 
The results of the preceding experiments indicate that some of the Nuo subunits 
may serve dual roles: they can act as structural components that participate in the 
enzymatic activities of complex I plus they can function in a regulatory capacity. A 
membrane-associated protein in S. typhimurium, PutA, is such a bifunctional enzyme. It 
both couples the oxidation of pro line to glutamate with the transfer of electrons directly 
to the electron transport chain in the cytoplasmic membrane and acts as a transcriptional 
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repressor that binds DNA to regulate the put operon in response to proline (85). The two 
activities are mutually exclusive and are determined in part by the cellular location of 
PutA (80). 
Both the NuoA and NuoH subunits contain putative DNA-binding regulatory 
domains, consistent with the hypothesis that each possesses regulatory activity. The 
NuoA subunit contains a LysR-like, helix-tum-helix DNA-binding motiflocated at its N-
terminus, consistent with other members of the LysR family (42, 97). The NuoH subunit 
contains an AraC-like, helix-tum-helix DNA-binding motif appropriately located at its C-
terminus (19, 42). The hypothesis that NuoA can act as a negative regulator is supported 
empirically by the decrease in promoter activity in cells overexpressing nuoA. The 
hypothesis that NuoH serves as a regulator is supported by the experiments in which the 
overexpression of nuoH-N resulted in a decrease in nuo promoter activity. 
Model for complex I Assembly 
The fungus Neurospora crassa assembles complete mitochondrial complex I en 
bloc from two independently assembled subcomplexes (25, 31, 34, 57, 81, 98, 100, 108). 
The peripheral arm, comprised of only nuclear-encoded subunits, was shown to assemble 
independently of the membrane arm (34); while the membrane arm, comprised of both 
nuclear- and mitochondrial-encoded subunits, was shown to assemble independently of 
the peripheral arm (98). Once both arms are made, they are assembled into a single 
enzyme complex at the mitochondrial matrix. If the NuoG homo log in N. crass a 
(Nuo78) is deleted, then only the membrane arm of complex I is detected, the peripheral 
82 
arm is not (41, 54). Similar results have been achieved after deleting other N. crassa (25, 
31, 57, 81, 100) or human (57) complex I subunits. If a subunit from one arm is mutated, 
the other arm can still subassemble. 
We hypothesize that E. coli complex I assembly also proceeds first by 
constructing independently assembled subcomplexes (Fig. 20). However, since E. coli 
harbors all of its nuo components in a single cellular compartment, it is logical that the 
regulation of expression and assembly would differ somewhat from that of the 
eukaryotes. This hypothesis is inferred from our mutant data. We did not detect any 
complex I activity or subcomplex formation in any of our nuo mutants, with the 
exception ofthe nuoNmutant, in which an NDF was detected. 
The following evidence supports the hypothesis of en bloc assembly of E. coli 
complex I: i) the conserved clustering of the nuo locus (38, 68), ii) the evolution of 
complex I (38-40, 68), iii) the detection of the NDF in the nuoN mutant (10), and iv) the 
observation that the NDF is properly assembled in the absence of the membrane fragment 
when NuoCD of the connecting fragment is present (14). On the basis of this 
information, we propose that the llnuoGJ and nuoG2 mutants cause the complex I defect 
because the altered NuoG subunits that they synthesize cannot be assembled into the 
NDF properly. This, in turn, prevents further assembly of other Nuo subunits. This 
hypothesis is supported by the inability to detect any Fe-S centers, present in the 
peripheral and connecting fragments, by EPR spectroscopy in the llnuoG 1 mutant. 
► 
II 
Fig. 20. Model for complex I assembly. The NuoCD subunit of the connecting 
fragment is necessary for the peripheral subunits NuoE, NuoF, and NuoG to form 
the peripheral fragment (NDF). Once the NDF and NuoCD have assembled, the 
remaining connecting fragment subunits (NuoB and Nuol) can assemble. Next, 
the membrane fragment assembles. It is unclear whether the membrane fragment 
assembles with the rest of the subassembled complex I as a block or one subunit at 
a time. 
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To address the hypothesis that the l:,,.nuoGJ and nuoG2 mutations result in altered 
NuoG subunits that cannot assemble into an NDF, a system similar to that used by Braun 
and colleagues (14) can be employed. They have already established a system whereby 
they can demonstrate formation of the NDF independent of the membrane fragment when 
nuoB-G are expressed from an expression vector. In their system, wild-type nuoB-G is 
cloned into an expression vector. That same system could be used where nuoB-l:,,.nuoG 1 
or nuoB-nuoG2 are cloned into the vector instead. Then cells transformed with these 
expression constructs can be evaluated for their ability to assemble an NDF. 
Furthermore, non-polar mutations introduced into nuoB, nuoC, or nuoD in the expression 
constructs could provide information concerning which of the connecting subunits are 
necessary for the assembly process. In conjunction with these genetic experiments, 
pulse-labeling and immunoprecipitation experiments similar to those employed by N. 
crassa complex I researchers (34) can be performed to witness the formation ofNDF 
assembly intermediates. 
Model for the Regulation of nuo Expression 
Perhaps throughout its evolution, the nuo locus retained its precursors' regulatory 
components to coordinate regulation of all its components, ensuring proper expression 
and assembly of a complete and functional complex I. On the basis of our findings, we 
hypothesize that E. coli cells can sense whether all of the Nuo subunits have been 
synthesized and assembled, utilizing some form of feedback mechanism to regulate the 
expression of nuo (Fig. 21 ). This mechanism would allow the cell to shut-down 
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Fig. 21. Model for the feedback mechanism of regulation of nuo expression. The 
llnuoG 1 mutant synthesizes a shortened, defective form of the NuoG subunit. This 
altered NuoG subunit is unable to assemble as part of the NDF and therefore into the 
complete complex I. Consequently, the connecting and membrane fragments are also 
unable to assemble into the complete complex I. As a result, either the membrane 
fragment and/or the subunits that constitute the membrane fragment are in excess in the 
cytoplasm and are able to repress transcription from the nuo promoter. Thus, the Nuo 
subunits participate in the regulation of nuo expression. This mechanism would allow 
the cell to shut down expression of nuo when a functional complex I can not be made. 
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expression of nuo when a functional complex I could not be made. Feedback 
mechanisms are used by a number of other large protein complexes in E. coli, e.g. the 
flagellar apparatus (70) and ribosomes (84, 121) to coordinately regulate their expression 
and assembly. 
The data that supports our hypothesis for feedback regulation of E. coli complex I 
is as follows. First, the llnuoGJ and nuoG2 mutants do not make a functional complex I. 
Second, these mutants synthesize defective forms of the NuoG subunit but, presumably, 
synthesize all other Nuo subunits. Third, activity from the nuo promoter is reduced i) in 
the llnuoGJ and nuoG2 mutants, ii) in cells that overexpress nuoA, and iii) in cells that 
overexpress nuoH-N. These data may reflect separate, unrelated aspects of regulation; 
alternatively, these data may provide insight into the overall regulatory network. Finally, 
the reduced promoter activity observed in the llnuoGJ and nuoG2 mutants is repressed 
by the absence ofNuoH-N. As stated above, we hypothesize that the altered NuoG 
subunits cannot properly incorporate into the NDF. Then, in tum, the NDF would not be 
available, so some or all of the components of the membrane fragment cannot associate 
with the connecting fragment. This would cause the membrane subunits or the membrane 
fragment to be in excess in the cytoplasm. Perhaps NuoA, NuoH, or a complete 
subassembled membrane fragment could reduce expression of nuo by inhibiting 
transcription at the nuo promoter. 
The feedback regulation model we present concerning Nuo subunits affecting nuo 
regulation arose from our studies with multi-copy operon and protein fusions. To 
strengthen the physiological relevance of our results, it would be necessary to move to 
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single-copy fusion studies. For example, we could further address the impact ofNuoA on 
the nuo promoter by using a single-copy nuoP: :lacZYA operon fusion in conjunction with 
an inducible expression construct expressing nuoA. IfNuoA does act as a repressor, then 
we would expect to observe a reduction in promoter activity from the single-copy fusion 
when nuoA expression is induced. Additionally, our model implies that one or more Nuo 
subunits interact directly with the nuo promoter. There are a number of experimental 
approaches that can be used to determine whether Nuo subunits bind the promoter. First, 
the subunits of interest (for instance NuoG, NuoA, and NuoH) need to be synthesized and 
purified. Then a variety of in vitro molecular techniques, such as gel shift analysis and 
DNase I footprinting studies, can be employed to determine whether those subunits do, in 
fact, bind to the nuo promoter and, more specifically, where that binding occurs on the 
DNA. Using antibodies directed against those subunits, the specificity of binding can be 
addressed. 
Sigma Factor Regulation 
A great deal of information has been attained concerning external regulators of 
nuo. Researchers have demonstrated a role for both electron acceptors and electron 
donors (12, 106) as well as global transcriptional regulators (12) in the regulation of nuo 
expression. These studies provide insight into the environmental stimuli that affect nuo 
expression. However, studies concerning which sigma factor(s) is responsible for nuo 
expression have not been performed. Here, we present the first data concerning that 
topic. 
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We measured the ~-galactosidase activity in three mutants transformed with the 
nuoPA '::lacZ operon fusion, each defective in one of three (69) E. coli sigma factors, 0 70, 
as, and 0 54• We observed that ~-galactosidase activity was significantly decreased only in 
cells defective for 0 54 (RpoN) but not for either 0 70 (RpoD) or as (RpoS). Contrary to 
earlier speculation (3, 12, 114), these findings suggest that the major sigma factor of 
exponential growth, 0 70, is not likely to be the major sigma factor controlling nuo 
expression. Furthermore, according to our results, as, the major sigma factor during 
stationary phase and the response to oxidative stress, also does not appear to be the major 
sigma factor contributing to nuo expression. Instead, our results are consistent with 0 54, 
the sigma factor responsible for nitrate and formate metabolism and anaerobic gene 
expression, serving as the major sigma factor regulating nuo expression. While the -10/-
35 0 70- binding consensus sequences in any one promoter is not highly conserved (45), 
0 54-dependent promoters conform to a precise consensus sequence TGGCAC-N5-
TTGCa/t located between -26 and -11 (76, 79). Surprisingly, we did not find this 
consensus sequence anywhere within the nuo promoter. This suggests that 0 54 may i) 
bind to some region of the promoter other than the known consensus sequence or ii) that 
a54 may work through an intermediate to regulate nuo expression, perhaps in conjunction 
with another sigma factor(s). The most likely candidates are still 0 70 and as. One 
hypothesis is that both 0 70 and as initiate transcription from the nuo promoter, but only in 
the presence of some factor, factor X, expressed by a54• If either 0 70 or as are absent, the 
system does not get shut-down. However, if 0 54 is absent, then factor X cannot be 
synthesized and neither 0 70 nor as can function. 
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It is clear from our data that the role of sigma factors in the regulation of nuo 
expression should be analyzed further. There are no studies addressing the role of sigma 
factors in the regulation of any of the components of the respiratory chains ( 4 7). Our 
results establish a role, direct or indirect, for 0 54 in the expression of nuo yet do not 
completely rule out a role for either 0 70 or as. It is necessary to determine which of the 
sigma factors bind the nuo promoter. DNasel footprinting and gel shift analyses have 
proven to be reliable techniques for addressing this question (15, 49). To further define 
the sigma factor/promoter interactions, in vitro transcription with reconstituted 
holoenzyme also can be employed (105). Of course, it is possible that the 0 54 effect we 
observed is indirect. Then, it would be necessary to identify what intermediate(s) through 
which 0 54 functions. This might be accomplished using an E. coli library in conjunction 
with the nuoPA '::/acZYA operon fusion to identify genes that affect nuo transcription 
through 0 54. 
Long-term Goal 
Thinking further into the future, a long-term goal may be to address how the 
mechanism of nuo regulation works in concert with that of other respiratory chain 
elements to balance a cell's redox state and to maximize its energy production. We 
already understand to some degree, the environmental factors that regulate expression of 
the respiratory chain enzymes. A more in depth examination of the coordinated 
mechanisms will provide a great deal of insight into how energy metabolism is regulated 
in the cell. 
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